Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AC026464.4 ENSG00000260914 16 69299682-69322700 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.3" "Cell type enriched" "Detected in single" 11 "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA060092 Approved Midbody NA NA Midbody "HPA060092: AB_2684203" "unprognostic (2.95e-1)" "unprognostic (4.21e-1)" "unprognostic (7.34e-2)" "unprognostic (8.50e-2)" "unprognostic (1.02e-1)" "unprognostic (2.74e-1)" "unprognostic (3.50e-1)" "unprognostic (4.08e-2)" "unprognostic (6.51e-4)" "unprognostic (1.69e-1)" "unprognostic (2.76e-1)" "unprognostic (5.11e-2)" 5.6 3.4 1.0 2.7 2.2 2.3 4.8 15.1 6.8 5.5 4.5 3.1 9.1 0.6 5.0 7.5 2.0 5.0 1.0 1.3 3.3 1.4 7.3 2.4 1.0 6.4 5.7 7.1 3.9 3.0 3.0 2.7 3.7 3.0 19.4 6.4 4.6 3.5 1.2 4.4 3.1 1.3 5.3 3.0 4.5 5.1 17.5 19.5 24.9 19.1 15.9 28.3 21.1 22.5 20.0 23.6 22.2 18.2 19.3 13.3 28.6 19.4 30.6 20.2 25.4 12.5 21.5 30.0 22.9 15.6 17.6 22.4 19.5 19.6 13.2 10.7 17.0 11.0 12.6 23.0 21.3 18.1 16.3 26.9 25.3 28.0 17.4 25.2 18.6 21.5 10.7 24.8 29.5 21.2 10.4 19.1 14.8 9.7 32.6 13.5 28.6 14.3 14.6 24.6 13.7 38.4 12.8 16.4 15.1 18.1 15.1 26.4 28.6 20.5 24.5 21.5 37.1 26.6 50.6 28.9 8.0 34.0 11.1 17.7 24.9 23.6 14.1 22.0 17.5 21.2 28.3 19.5 15.7 21.8 21.3 12.4 15.9 19.1 13.4 19.9 21.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAMTS18 ADAMTS21 ENSG00000140873 "ADAM metallopeptidase with thrombospondin type 1 motif 18" Q8TE60 16 77247813-77435114 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adipose tissue: 16.1;brain: 31.9;placenta: 27.6" "Group enriched" "Detected in some" 6 "Muller glia cells: 16.4;Rod photoreceptor cells: 8.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in all" 5 "cerebellum: 31.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 13.2;HUVEC TERT2: 8.9;SuSa: 12.5;U-87 MG: 5.5" "Region enriched" "Detected in single" 5 "cerebellum: 3.7" "Not detected" "Not detected" HPA044326 Uncertain Approved "Midbody,Mitotic spindle" "Secreted to extracellular matrix" Yes NA "Midbody, Mitotic spindle" "HPA044326: AB_10961006" "unprognostic (1.10e-2)" "unprognostic (2.78e-1)" "unprognostic (1.38e-1)" "unprognostic (2.50e-1)" "unprognostic (8.13e-2)" "unprognostic (2.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.27e-2)" "unprognostic (2.46e-2)" "unprognostic (2.98e-1)" "unprognostic (4.11e-2)" "unprognostic (2.20e-2)" "unprognostic (8.17e-4)" "unprognostic (1.77e-5)" "unprognostic (2.17e-1)" "unprognostic (3.41e-1)" "unprognostic (2.47e-4)" 16.1 0.6 1.1 0.8 5.1 0.4 3.2 31.9 3.3 2.2 0.4 8.2 0.0 0.5 1.6 0.4 0.5 0.7 1.1 0.4 2.0 1.3 0.5 0.3 0.5 0.5 1.8 1.4 0.5 0.8 0.4 1.4 27.6 6.4 1.0 0.4 0.2 2.1 0.5 1.0 0.4 0.4 1.2 3.7 0.3 0.3 0.7 2.4 0.0 0.4 0.0 0.3 0.8 0.4 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 12.5 0.0 0.5 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.1 5.1 31.9 3.3 2.0 1.3 1.8 1.4 6.4 2.4 0.0 0.0 0.0 0.1 0.1 0.4 0.5 0.0 0.0 0.0 1.8 2.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.0 0.0 ADAMTS19 ENSG00000145808 "ADAM metallopeptidase with thrombospondin type 1 motif 19" Q8TE59 5 129460265-129738683 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 16.6;endometrium 1: 14.6;smooth muscle: 9.0" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 15.3;Syncytiotrophoblasts: 4.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "MCF7: 12.0;SH-SY5Y: 27.6" "Region enriched" "Detected in single" 5 "olfactory region: 4.8" "Low region specificity" "Detected in all" "HPA056171, HPA058438" Uncertain Approved Vesicles,Midbody "Secreted to extracellular matrix" Yes NA "Vesicles, Midbody" "HPA056171: AB_2683054, HPA058438: AB_2683718" "unprognostic (1.14e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.10e-3)" "unprognostic (1.09e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-2)" "unprognostic (4.17e-2)" "unprognostic (5.99e-3)" "unprognostic (5.17e-1)" "unprognostic (1.14e-1)" "unprognostic (5.88e-2)" "unprognostic (3.06e-2)" 0.2 1.2 0.7 0.6 3.6 0.1 0.2 0.0 4.9 16.6 0.5 1.2 0.0 0.4 14.6 0.3 1.5 2.6 0.8 0.5 1.0 0.8 0.7 0.1 0.2 0.2 0.5 4.3 2.8 0.2 0.2 0.1 5.3 1.8 0.4 0.6 0.9 1.1 0.2 0.8 0.2 0.3 9.0 1.0 0.2 0.2 0.4 0.8 0.0 0.1 1.8 0.1 0.9 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 12.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 27.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.6 0.0 4.9 1.0 0.8 0.5 4.3 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.8 0.0 15.3 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.0 0.0 0.0 ANKRD54 LIAR ENSG00000100124 "Ankyrin repeat domain 54" Q6NXT1 22 37830855-37849327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071287 Approved Approved Nucleoplasm,Microtubules,Midbody Yes No "Microtubules, Midbody" Nucleoplasm "HPA071287: AB_2686380" "unprognostic (5.36e-2)" "prognostic favorable (2.06e-4)" "unprognostic (1.02e-1)" "prognostic favorable (7.38e-5)" "unprognostic (1.14e-1)" "unprognostic (1.50e-1)" "unprognostic (1.65e-2)" "unprognostic (1.77e-2)" "unprognostic (1.06e-1)" "unprognostic (3.41e-2)" "prognostic favorable (6.16e-4)" "unprognostic (2.53e-1)" "unprognostic (6.33e-2)" "unprognostic (1.13e-1)" "unprognostic (5.07e-2)" "unprognostic (1.89e-1)" "unprognostic (3.02e-3)" 7.8 14.8 18.4 7.9 15.8 7.5 9.1 20.0 19.5 13.5 11.9 14.1 17.4 9.8 11.2 14.9 13.6 33.5 11.4 8.9 17.1 20.6 13.0 11.9 9.3 8.1 14.2 12.1 19.0 24.6 15.3 16.4 7.9 14.8 13.1 9.4 13.4 19.1 16.3 9.3 11.8 9.5 13.5 11.7 7.5 8.9 23.7 11.0 12.3 18.2 8.7 9.8 11.6 13.9 6.2 6.7 3.5 10.0 12.8 6.9 3.8 10.9 11.1 9.4 13.8 12.7 7.1 5.0 15.2 11.7 25.8 15.8 7.0 4.3 10.6 6.3 9.9 8.3 9.8 12.0 8.4 12.5 8.5 24.2 5.3 10.1 16.7 11.3 10.5 12.8 6.4 8.8 13.9 8.2 6.3 15.7 7.9 7.0 7.4 11.7 11.5 10.2 12.1 2.7 14.7 10.2 11.9 11.5 6.6 14.2 3.6 16.4 8.8 12.7 11.3 18.0 4.4 11.6 16.7 9.1 15.0 16.2 7.8 11.1 8.3 6.7 8.4 12.5 9.0 10.8 2.6 5.4 2.4 6.8 6.4 6.8 4.5 6.6 5.2 6.7 6.2 6.9 3.4 3.5 12.8 10.0 6.7 2.8 3.8 18.4 15.8 20.0 19.5 17.1 20.6 14.2 12.1 14.8 11.0 11.9 16.4 13.9 9.0 14.1 17.4 7.1 22.9 33.5 11.4 17.4 27.5 18.3 33.2 14.5 5.0 9.0 15.5 0.0 12.7 15.1 10.4 8.9 9.2 9.6 11.6 25.4 8.6 11.1 8.1 6.0 16.7 9.5 10.1 8.2 12.6 16.9 11.3 15.2 20.1 14.7 22.1 6.5 14.4 54.6 39.2 15.4 14.1 16.0 14.4 8.8 ANLN "ANILLIN, scra, Scraps" ENSG00000011426 "Anillin actin binding protein" Q9NQW6 7 36389806-36453791 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.4;lymphoid tissue: 32.7" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 106.8;Late spermatids: 41.2;Spermatocytes: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HBF TERT88: 100.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005680, CAB033902, HPA050556, CAB062547, CAB068175" Enhanced Enhanced Nucleoplasm,Midbody Yes Yes Nucleoplasm Midbody "CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175" "unprognostic (4.23e-2)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.67e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (5.97e-7)" "prognostic unfavorable (6.99e-5)" "unprognostic (2.69e-2)" "unprognostic (3.66e-2)" "prognostic unfavorable (2.00e-6)" "unprognostic (3.13e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.29e-2)" "unprognostic (1.34e-1)" "unprognostic (2.94e-2)" "unprognostic (4.04e-3)" 1.7 0.6 13.9 7.2 10.5 20.9 1.3 1.8 36.7 1.9 3.9 1.6 0.0 2.9 1.3 2.4 12.8 0.6 1.4 0.6 24.0 12.1 0.7 0.8 3.3 4.2 30.5 2.5 0.9 0.4 0.3 0.3 12.9 9.7 0.7 5.5 0.0 0.9 0.3 0.4 8.9 3.4 9.4 63.4 1.6 3.3 9.2 12.5 32.7 0.6 17.7 6.7 2.6 1.3 0.0 0.3 0.6 0.9 0.0 1.7 2.0 68.4 14.4 12.0 9.1 1.6 4.2 12.9 43.2 25.3 52.2 39.2 9.8 21.2 3.4 12.5 21.8 27.8 35.3 9.4 25.2 100.3 2.3 6.8 4.7 16.2 8.1 0.2 6.7 5.5 0.9 1.1 34.0 22.4 6.2 16.2 4.6 9.8 7.3 42.5 10.3 5.7 7.8 13.3 10.5 15.2 4.2 36.0 2.3 11.5 11.2 5.1 6.0 22.7 26.4 3.9 17.4 17.8 7.7 15.3 32.7 36.8 19.2 50.4 3.0 4.8 6.4 11.1 10.9 68.6 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.9 0.5 0.3 0.0 0.6 0.0 0.6 0.0 0.3 0.2 1.7 2.0 13.9 10.5 1.8 7.7 24.0 12.1 30.5 2.5 9.7 12.5 0.0 0.6 0.0 1.0 12.6 0.0 0.6 0.0 2.7 1.2 0.0 0.0 2.5 0.0 0.5 106.8 0.1 0.9 0.0 0.2 20.2 3.5 1.3 0.0 0.0 8.0 0.0 0.0 1.8 1.5 41.2 1.1 2.6 0.0 0.0 2.2 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.4 20.9 14.9 8.2 2.4 1.5 1.6 1.4 AP002748.4 ENSG00000256349 11 66509079-66533613 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 3.4" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 1.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "NTERA-2: 16.3;THP-1: 4.1" HPA058283 Uncertain Uncertain Midbody NA NA Midbody "HPA058283: AB_2683667" 0.2 0.9 0.0 0.0 0.6 0.0 0.3 0.7 0.2 0.5 0.3 0.0 1.0 0.0 0.1 0.3 0.5 0.0 0.7 0.3 0.7 1.0 0.3 1.4 0.2 0.3 3.4 0.0 0.2 0.1 0.3 0.1 0.4 0.2 0.9 0.0 0.3 0.7 0.3 0.5 0.4 0.0 0.5 0.4 0.7 0.1 0.0 0.7 0.0 1.2 0.6 0.8 1.0 0.9 0.0 0.6 0.0 0.0 0.0 0.5 0.5 0.5 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.7 0.0 0.3 1.2 0.0 0.0 0.3 1.7 0.2 0.0 1.8 0.2 0.8 0.0 0.6 0.2 0.5 16.3 0.9 0.0 0.9 0.0 0.0 0.3 0.8 0.3 0.0 0.3 0.4 0.6 0.2 1.4 4.1 0.0 0.7 0.1 0.0 0.1 0.0 0.2 0.7 0.0 0.2 0.4 0.0 0.2 0.0 0.2 1.2 0.7 0.0 0.3 0.5 0.7 0.0 0.3 0.0 0.0 0.6 0.3 0.5 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APC2 APCL ENSG00000115266 "APC2, WNT signaling pathway regulator" O95996 19 1446302-1473244 "Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 59.4" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 41.9;Horizontal cells: 42.9;Muller glia cells: 26.1;Rod photoreceptor cells: 10.3" "Cancer enriched" "Detected in some" 27 "glioma: 17.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 6.5;SCLC-21H: 7.8;SH-SY5Y: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078002 Supported "Cytokinetic bridge,Midbody,Cytosol" Yes No "Cytokinetic bridge, Midbody" Cytosol "HPA078002: AB_2686874" "unprognostic (1.78e-3)" "unprognostic (1.65e-1)" "unprognostic (2.88e-5)" "unprognostic (3.64e-2)" "unprognostic (3.59e-1)" "unprognostic (1.52e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (1.38e-2)" "unprognostic (1.30e-2)" "unprognostic (3.45e-2)" "unprognostic (9.49e-3)" "unprognostic (7.39e-2)" "unprognostic (3.70e-2)" "unprognostic (4.99e-2)" "unprognostic (1.98e-3)" 1.5 4.7 17.3 1.4 16.4 1.5 1.3 21.7 59.4 1.4 1.6 20.7 0.0 2.1 1.4 1.4 1.4 1.5 1.6 1.4 16.8 13.9 1.3 1.3 1.4 1.4 15.0 14.0 1.3 2.0 1.3 3.0 1.4 17.1 1.4 1.4 0.8 1.7 1.4 1.6 1.4 1.8 1.5 13.9 1.4 1.4 1.8 14.5 0.0 1.5 0.0 1.3 1.6 0.0 1.1 0.2 0.4 0.0 0.0 0.1 0.1 0.2 0.5 6.5 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.1 0.0 0.4 0.2 0.1 0.0 0.0 0.9 0.3 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.1 0.1 0.2 0.1 0.1 0.0 0.4 0.1 0.0 0.7 0.0 0.0 7.8 26.5 0.9 0.0 0.4 0.1 0.1 0.0 0.0 0.5 0.5 0.2 0.2 1.9 0.4 0.3 0.7 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 17.3 16.4 21.7 21.3 16.8 13.9 15.0 14.0 17.1 14.5 0.0 0.0 0.0 0.1 0.0 41.9 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 42.9 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.7 0.0 10.3 0.0 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.1 AURKB "Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5" ENSG00000178999 "Aurora kinase B" Q96GD4 17 8204733-8210600 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.7;lymphoid tissue: 59.9" "Group enriched" "Detected in many" 6 "Erythroid cells: 46.7;Extravillous trophoblasts: 76.2;Hofbauer cells: 23.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.9" "Lineage enriched" "Detected in many" 5 "T-cells: 10.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB005862, HPA037708" Enhanced Enhanced Nucleoplasm,Midbody Yes Yes Nucleoplasm Midbody "CAB005862: AB_449204, HPA037708: AB_2675623" "unprognostic (4.76e-2)" "unprognostic (3.61e-3)" "unprognostic (2.25e-1)" "unprognostic (3.14e-2)" "unprognostic (2.27e-1)" "unprognostic (6.05e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.99e-3)" "unprognostic (9.41e-3)" "unprognostic (3.47e-2)" "unprognostic (4.61e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.77e-2)" "unprognostic (2.93e-1)" "unprognostic (6.76e-2)" "unprognostic (3.77e-1)" 1.2 1.3 0.4 22.1 0.6 19.7 2.0 0.6 0.6 2.6 5.8 0.5 0.9 5.9 0.9 1.3 17.1 0.3 2.2 1.0 0.4 0.2 1.4 1.8 2.4 17.8 0.4 0.4 0.8 0.6 0.0 0.4 3.8 0.8 0.9 5.5 0.7 2.7 0.4 2.1 5.0 8.1 1.3 0.7 11.2 4.2 1.2 0.4 59.9 0.5 8.0 19.1 2.1 5.0 2.3 0.8 1.2 0.6 0.5 10.9 1.4 41.6 28.6 42.7 20.5 0.9 1.4 16.4 20.0 10.8 41.5 38.3 37.0 12.6 41.6 10.4 7.9 17.3 30.7 30.9 13.7 34.3 18.2 50.8 24.8 16.4 31.2 0.1 13.0 24.4 0.7 0.6 24.3 15.2 4.1 19.0 27.4 15.4 16.1 18.1 19.8 47.5 18.6 26.5 13.7 12.7 32.2 39.3 17.2 9.0 8.2 9.3 13.2 17.8 8.0 13.6 13.3 14.0 8.8 7.4 16.6 17.1 14.9 52.0 11.8 7.8 31.3 8.0 19.9 33.6 0.0 0.6 0.9 0.6 0.4 0.2 1.6 1.9 3.1 0.8 2.3 0.2 1.0 1.2 0.5 0.3 0.2 10.9 1.4 0.4 0.6 0.6 0.6 0.4 0.2 0.4 0.4 0.8 0.4 0.0 0.3 2.2 0.3 3.9 0.0 1.1 0.0 0.0 3.4 0.0 0.0 5.1 0.0 0.2 0.0 0.0 1.4 46.7 0.0 76.2 4.7 0.4 4.6 0.6 23.9 0.0 0.0 4.9 6.3 0.0 0.6 4.4 1.7 0.0 4.2 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.3 0.7 2.0 2.0 7.6 2.5 6.3 1.4 BBS1 FLJ23590 ENSG00000174483 "Bardet-Biedl syndrome 1" Q8NFJ9 11 66510606-66533627 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Olfaction, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 14.7;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 11.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA058283 Uncertain Uncertain Midbody NA NA Midbody "HPA058283: AB_2683667" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.14e-1)" "unprognostic (1.56e-1)" "unprognostic (1.08e-3)" "unprognostic (1.40e-2)" "unprognostic (6.68e-2)" "unprognostic (1.72e-2)" "unprognostic (2.76e-1)" "unprognostic (1.19e-3)" "unprognostic (2.61e-2)" "unprognostic (6.05e-2)" "unprognostic (3.04e-1)" "unprognostic (2.20e-1)" "unprognostic (2.38e-1)" "unprognostic (4.87e-4)" 9.0 14.1 17.3 6.1 24.7 3.4 12.4 23.0 32.7 21.3 13.7 15.5 16.5 7.3 21.9 19.9 10.0 30.2 14.5 10.5 13.9 15.8 26.2 7.7 11.5 5.4 11.4 20.4 30.4 14.3 44.6 21.4 9.2 14.8 17.6 8.5 22.7 17.2 25.0 6.5 9.5 7.7 15.8 8.4 6.4 12.2 11.0 9.5 8.0 28.8 6.2 7.7 14.7 9.7 4.7 2.3 2.0 5.0 5.3 5.2 3.1 4.1 4.2 10.0 3.9 18.9 13.4 4.4 3.4 6.9 5.3 4.4 6.9 7.3 0.5 7.4 8.6 4.1 7.6 7.4 7.6 5.0 3.7 4.5 1.7 5.3 3.9 8.8 3.1 1.0 13.4 7.2 7.0 5.3 13.2 6.9 6.1 3.8 2.7 5.6 3.6 2.7 3.3 6.0 12.6 7.9 6.9 6.5 5.1 14.4 5.2 10.1 6.8 5.7 6.4 13.1 5.3 13.3 1.5 6.6 3.8 4.3 4.4 1.1 2.4 1.1 1.0 12.7 0.9 4.2 0.0 3.0 0.5 4.0 3.2 5.2 4.7 5.1 4.2 2.3 2.4 3.8 4.8 2.0 5.3 5.0 1.1 1.6 3.1 17.3 24.7 23.0 32.7 13.9 15.8 11.4 20.4 14.8 9.5 0.0 2.1 0.0 1.1 0.5 4.2 0.4 0.0 14.7 1.2 0.0 7.9 1.3 0.0 0.6 3.9 0.6 0.1 0.0 0.3 0.6 1.1 0.9 0.0 0.0 0.5 0.0 1.2 0.6 1.6 0.6 0.9 0.3 0.0 1.0 0.4 1.2 0.4 0.0 1.4 1.3 11.5 0.0 0.5 4.9 2.5 0.9 0.8 0.0 0.8 1.0 BCL3 "BCL4, D19S37" ENSG00000069399 "B cell CLL/lymphoma 3" P20749 19 44747705-44760044 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 16.5" "Lineage enriched" "Detected in all" 6 "granulocytes: 16.5" "Cell line enhanced" "Detected in many" "HDLM-2: 27.0;Karpas-707: 22.4;SiHa: 28.7;U-266/70: 21.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002051, HPA047514" Approved Supported Nucleoplasm,Vesicles,Midbody Yes No Nucleoplasm "Vesicles, Midbody" "CAB002051: AB_563428, HPA047514: AB_2680074" "prognostic favorable (9.67e-4)" "unprognostic (8.82e-2)" "unprognostic (2.81e-1)" "unprognostic (7.54e-2)" "prognostic unfavorable (4.01e-4)" "unprognostic (3.49e-2)" "unprognostic (2.34e-3)" "unprognostic (2.79e-1)" "prognostic favorable (3.74e-4)" "unprognostic (2.09e-2)" "unprognostic (9.23e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.13e-14)" "unprognostic (8.24e-2)" "unprognostic (1.36e-1)" "unprognostic (3.77e-2)" "unprognostic (3.04e-2)" 17.7 13.0 4.0 21.1 5.6 35.2 18.7 1.4 4.7 11.7 14.9 2.4 5.9 24.5 10.4 9.7 27.1 12.5 22.7 20.1 3.9 2.0 17.8 52.1 36.4 20.5 4.3 0.5 26.5 13.2 2.4 9.2 9.5 5.6 16.0 8.0 8.8 13.7 13.7 20.2 9.0 35.5 11.5 6.5 41.6 15.0 8.3 4.0 6.5 13.9 22.9 37.0 18.7 11.9 1.3 2.6 16.5 2.4 1.8 1.5 0.7 3.9 13.6 0.3 7.2 2.6 5.5 0.7 2.4 2.6 1.5 2.2 2.8 7.2 3.9 5.6 4.8 8.0 4.4 0.9 4.1 1.0 27.0 0.2 0.5 7.1 3.6 6.3 0.3 11.6 9.6 3.2 3.4 4.3 7.1 4.1 0.0 0.5 22.4 0.9 3.3 0.0 3.0 0.3 6.0 5.7 1.8 2.7 1.4 6.9 8.2 0.0 0.4 28.7 14.7 0.7 0.5 5.1 3.0 6.9 4.9 5.1 7.6 0.9 21.3 8.3 4.0 9.1 0.5 3.7 0.2 2.4 4.2 0.7 1.6 1.0 1.3 0.9 1.1 2.1 1.1 0.5 0.6 16.5 1.8 0.9 2.6 1.5 0.7 4.0 5.6 1.4 4.7 3.9 2.0 4.3 0.5 5.6 4.0 17.9 53.0 18.6 32.7 41.4 1.7 2.4 25.5 18.7 31.8 12.2 0.0 0.3 8.3 26.4 9.3 39.0 55.4 0.0 58.8 5.9 33.8 37.5 36.9 31.7 13.9 7.9 20.6 35.6 31.1 1.3 12.4 45.8 38.8 36.9 31.6 2.3 42.1 35.1 4.2 17.7 0.5 6.5 57.5 0.5 1.2 53.3 1.1 14.6 22.9 44.4 CDK10 PISSLRE ENSG00000185324 "Cyclin dependent kinase 10" Q15131 16 89680737-89696364 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007451, HPA059634, HPA067060" Uncertain Supported "Nucleoplasm,Midbody,Midbody ring" Yes Yes Nucleoplasm "Midbody, Midbody ring" "HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772" "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (3.74e-3)" "unprognostic (9.87e-2)" "unprognostic (1.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.53e-1)" "unprognostic (9.06e-2)" "unprognostic (2.99e-1)" "unprognostic (2.13e-1)" "prognostic favorable (2.69e-4)" "unprognostic (2.58e-2)" "unprognostic (2.93e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (6.88e-2)" "prognostic favorable (3.63e-4)" 12.3 19.9 16.8 16.4 23.8 17.3 10.1 14.8 21.9 11.1 18.3 8.1 16.4 23.4 12.1 21.7 14.4 14.4 19.4 8.7 15.3 12.6 22.2 33.9 11.8 14.0 13.3 19.4 11.3 22.2 21.6 27.7 13.6 15.8 13.6 12.6 8.1 17.2 8.9 17.5 14.1 20.7 9.0 10.7 15.9 19.0 8.7 13.6 8.0 27.1 10.1 12.1 10.8 14.5 7.8 14.5 3.4 15.3 15.2 13.3 8.8 14.7 9.6 7.7 3.1 3.2 6.1 8.1 12.2 6.9 8.7 2.9 7.4 11.2 13.1 6.2 10.5 5.4 10.3 3.3 17.0 5.5 2.9 8.1 5.1 10.8 0.8 13.4 8.3 9.4 7.5 5.7 5.5 8.3 5.8 15.1 8.7 13.4 1.8 9.9 19.2 10.0 23.8 15.8 16.0 7.3 14.6 10.5 18.4 15.6 11.7 7.6 16.5 15.3 7.1 3.6 9.1 16.7 13.2 13.4 5.9 15.3 6.1 8.3 6.6 3.6 4.0 9.0 14.3 8.4 3.2 11.7 3.4 12.9 15.3 10.9 6.8 11.4 8.9 14.5 7.8 13.3 10.9 1.5 15.2 11.2 10.0 8.8 8.8 16.8 23.8 14.8 21.9 15.3 12.6 13.3 19.4 15.8 13.6 11.9 28.2 16.7 22.2 13.7 17.3 4.8 45.9 18.7 9.1 26.2 23.6 25.3 36.5 23.6 5.0 17.5 42.9 0.0 11.0 16.4 18.6 26.1 9.2 37.6 16.3 17.5 65.1 19.6 16.7 5.4 22.2 13.0 18.6 14.4 38.5 10.3 14.2 35.1 11.7 45.1 33.8 6.5 11.3 23.1 29.8 13.6 23.3 17.5 50.1 18.6 CEACAM18 ENSG00000213822 "Carcinoembryonic antigen related cell adhesion molecule 18" A8MTB9 19 51478622-51490952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 62 "intestine: 31.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "pancreatic cancer: 0.8;stomach cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "CACO-2: 8.6;OE19: 7.0;RT4: 2.8" "Not detected" "Not detected" HPA059487 Uncertain Approved Midbody NA NA Midbody "HPA059487: AB_2684036" "unprognostic (1.12e-1)" "unprognostic (1.87e-2)" "unprognostic (1.00e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 16.6 0.0 0.0 14.6 0.1 0.0 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 31.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 7.0 0.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CENPC "CENP-C, CENPC1, hcp-4, MIF2" ENSG00000145241 "Centromere protein C" Q03188 4 67468748-67545606 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049740, HPA058252" Supported "Nucleoplasm,Nuclear bodies,Midbody" NA NA "Nuclear bodies" "Nucleoplasm, Midbody" "HPA049740: , HPA058252: AB_2683654" "unprognostic (4.35e-1)" "unprognostic (6.41e-3)" "unprognostic (4.31e-3)" "unprognostic (7.85e-2)" "unprognostic (6.31e-2)" "unprognostic (3.85e-3)" "unprognostic (6.40e-2)" "prognostic favorable (9.67e-4)" "unprognostic (3.22e-2)" "unprognostic (7.13e-2)" "unprognostic (8.35e-2)" "unprognostic (4.32e-2)" "prognostic favorable (5.63e-4)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" "unprognostic (1.92e-3)" 9.4 8.6 9.3 11.9 14.6 12.9 13.5 26.9 12.2 12.6 7.3 4.6 6.2 5.6 12.6 10.1 9.1 10.1 6.6 6.9 8.0 5.8 9.0 6.6 8.7 7.7 11.8 7.7 20.9 16.4 8.0 21.2 6.3 9.1 12.3 6.0 5.0 10.2 13.4 5.3 9.8 9.1 10.3 13.4 10.5 9.5 7.5 12.6 17.7 13.0 9.1 6.8 10.2 10.4 5.1 2.4 2.8 1.5 1.6 5.0 1.2 0.8 1.0 2.9 1.6 3.4 2.1 1.6 1.0 0.9 1.3 1.1 1.2 2.3 4.5 1.6 1.3 0.7 1.5 3.7 1.7 2.0 1.7 0.7 3.5 1.8 1.6 1.2 6.3 1.5 2.5 0.6 1.0 2.2 2.2 0.7 3.1 5.0 3.1 1.9 1.5 8.6 5.8 3.1 1.6 0.7 4.2 7.0 1.5 1.7 1.5 4.8 2.4 2.2 4.2 1.2 3.0 1.4 2.4 1.0 1.8 1.3 1.3 0.9 2.3 1.0 4.8 2.1 3.7 1.1 2.7 1.3 2.8 3.2 1.5 1.9 3.3 3.6 3.4 1.1 5.1 5.0 3.7 1.0 1.6 1.1 2.4 2.0 1.2 9.3 14.6 26.9 12.2 8.0 5.8 11.8 7.7 9.1 12.6 29.8 31.5 29.9 25.5 13.5 51.4 20.0 15.3 36.1 38.7 15.7 13.7 15.9 10.0 9.7 3.1 19.2 14.8 23.3 14.6 11.7 14.6 15.2 25.5 13.2 11.0 49.3 12.6 19.0 16.4 4.2 32.2 15.1 15.1 15.4 15.8 42.4 12.3 11.5 24.1 13.9 28.4 19.4 15.5 33.5 46.1 8.2 15.3 44.5 14.3 20.9 CENPV "CENP-V, p30, PRR6" ENSG00000166582 "Centromere protein V" Q7Z7K6 17 16342534-16353656 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Paneth cells: 96.8;Spermatogonia: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.6;memory B-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 33.0;HEK 293: 27.0;JURKAT: 32.1;NTERA-2: 32.4" "Low region specificity" "Detected in all" "HPA042529, HPA042616" Enhanced Approved Nucleoplasm,Midbody,Cytosol Yes No Nucleoplasm "Midbody, Cytosol" "HPA042529: AB_10793882, HPA042616: AB_10794050" "unprognostic (7.64e-2)" "unprognostic (4.41e-2)" "unprognostic (5.92e-2)" "unprognostic (9.66e-3)" "unprognostic (1.16e-1)" "unprognostic (1.32e-1)" "unprognostic (2.24e-1)" "unprognostic (6.47e-2)" "unprognostic (1.21e-1)" "unprognostic (4.00e-2)" "unprognostic (7.73e-3)" "unprognostic (7.93e-2)" "unprognostic (4.09e-3)" "unprognostic (2.58e-1)" "unprognostic (1.89e-2)" "unprognostic (2.54e-2)" "unprognostic (3.60e-3)" 4.6 5.6 13.7 4.0 14.7 6.2 6.6 12.0 17.3 4.2 19.5 6.7 2.8 13.6 8.0 5.5 1.3 9.1 3.5 5.7 10.2 10.1 5.2 14.6 2.5 2.3 7.8 11.8 9.1 5.9 3.7 7.3 2.2 5.8 4.6 11.5 2.4 1.6 6.4 25.4 0.9 29.1 6.1 7.3 1.5 18.0 10.6 6.1 22.5 4.0 2.9 2.1 3.2 2.3 3.3 1.0 3.6 0.0 0.0 1.0 0.3 3.1 6.2 33.0 16.6 0.9 0.8 5.7 2.6 2.6 8.3 6.4 6.2 1.4 12.6 5.3 1.9 1.5 0.9 21.3 0.2 5.2 0.0 27.0 2.9 1.6 12.2 9.3 3.0 0.0 2.4 0.8 10.0 5.8 0.9 4.6 32.1 5.1 0.0 2.4 0.5 23.6 10.0 32.4 20.5 0.0 17.0 1.2 1.4 1.9 4.7 17.7 13.5 6.6 0.1 1.5 15.9 0.1 7.4 0.3 0.0 2.7 0.3 0.0 0.0 0.0 7.3 0.0 4.1 0.2 0.0 0.0 3.6 0.3 0.0 0.1 3.3 0.1 0.1 0.7 0.3 1.0 0.9 0.0 0.0 0.0 1.0 0.2 0.3 13.7 14.7 12.0 17.3 10.2 10.1 7.8 11.8 5.8 6.1 0.0 2.4 6.0 17.3 0.9 40.2 3.7 28.1 4.0 6.8 1.8 3.9 11.5 26.6 7.1 12.4 3.6 48.0 0.0 20.1 10.7 2.9 19.6 5.7 43.9 5.4 11.1 37.8 1.3 2.2 6.1 8.1 2.7 8.5 1.0 52.7 28.8 13.5 96.8 11.0 31.1 13.8 25.8 15.6 48.8 116.2 2.3 5.4 4.3 71.8 42.2 CEP55 "C10orf3, CT111, FLJ10540" ENSG00000138180 "Centrosomal protein 55" Q53EZ4 10 93496632-93529092 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 52.9;testis: 19.3" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 15.9;Extravillous trophoblasts: 14.7;Hofbauer cells: 10.9;Spermatocytes: 35.6;Spermatogonia: 19.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "T-reg: 4.4" "Lineage enriched" "Detected in single" 24 "T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA023430 Approved Supported "Plasma membrane,Midbody,Centriolar satellite" Yes Yes "Plasma membrane, Centriolar satellite" Midbody "HPA023430: AB_10960212" "unprognostic (9.85e-2)" "unprognostic (1.12e-2)" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (4.26e-2)" "prognostic unfavorable (3.20e-9)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.50e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.66e-5)" "unprognostic (3.99e-2)" "prognostic unfavorable (0.00e+0)" "prognostic favorable (3.15e-4)" "unprognostic (7.86e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" 3.2 1.4 0.5 12.1 0.4 3.1 3.6 0.3 0.6 2.0 5.2 0.3 0.2 4.6 0.8 1.5 11.6 0.6 2.5 0.7 0.4 0.5 1.5 0.7 4.4 10.1 0.6 0.2 0.8 0.6 0.0 0.7 3.8 0.5 0.8 6.5 0.4 2.3 0.2 0.7 3.0 5.2 3.5 1.1 4.8 3.2 19.3 0.3 52.9 0.7 10.8 11.0 2.7 3.3 0.1 0.1 0.0 0.0 0.0 4.4 0.0 51.9 20.8 13.8 17.6 1.5 3.2 7.7 28.6 20.3 27.2 28.2 22.1 28.0 13.9 12.7 18.5 18.3 29.7 16.7 14.0 32.7 41.8 8.7 5.2 12.9 7.5 0.1 9.0 12.2 0.7 1.0 29.0 35.4 8.1 25.0 23.1 4.7 26.4 30.7 12.0 23.7 13.7 5.4 16.2 15.2 10.3 22.7 7.6 12.3 6.5 5.7 8.0 22.0 6.8 17.3 11.0 17.9 9.2 15.6 17.3 24.2 23.6 46.9 11.8 16.0 17.0 13.5 34.0 15.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.5 0.4 0.3 0.6 0.4 0.5 0.6 0.2 0.5 0.3 0.0 2.2 0.8 0.6 3.2 0.0 0.4 5.1 0.0 0.0 0.0 0.0 0.9 0.0 0.6 15.9 0.0 0.3 0.0 0.2 14.7 0.4 0.1 0.0 0.2 10.9 0.0 0.0 2.5 4.1 3.8 0.3 5.4 0.0 0.0 1.4 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 35.6 19.5 1.1 1.3 1.9 2.3 0.9 CFAP53 "CCDC11, FLJ32743" ENSG00000172361 "Cilia and flagella associated protein 53" Q96M91 18 50227193-50266522 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Ciliopathy, Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.1;fallopian tube: 19.7;testis: 44.9" "Group enriched" "Detected in many" 11 "Ciliated cells: 397.5;Early spermatids: 589.3;Late spermatids: 341.5;Spermatocytes: 416.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "pons and medulla: 17.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 9.5" "Low region specificity" "Detected in some" "HPA041069, HPA066142" Enhanced Approved Midbody Yes No Midbody "HPA041069: AB_10805835, HPA066142: AB_2732739" "unprognostic (1.73e-2)" "unprognostic (1.13e-2)" "unprognostic (5.83e-2)" "unprognostic (3.12e-3)" "unprognostic (3.31e-2)" "unprognostic (1.19e-1)" "unprognostic (3.64e-4)" "unprognostic (2.90e-2)" "unprognostic (3.68e-2)" "unprognostic (9.75e-3)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" "prognostic favorable (5.85e-4)" "unprognostic (3.22e-1)" "unprognostic (1.17e-2)" "unprognostic (4.34e-3)" "unprognostic (4.61e-3)" 0.4 1.0 2.1 0.4 4.8 0.6 1.0 2.9 1.0 1.6 0.3 4.9 1.7 0.4 1.0 9.3 0.3 19.7 0.7 0.4 2.7 3.3 2.2 0.4 4.5 0.4 1.0 1.1 4.8 1.6 2.7 12.3 0.4 17.1 1.1 0.3 1.2 0.8 2.5 1.4 0.9 0.4 0.5 1.4 0.4 0.5 44.9 2.2 0.2 4.3 0.0 0.4 0.5 0.4 2.1 1.0 2.2 1.0 1.4 1.2 0.4 2.4 1.6 1.0 2.0 1.4 2.7 1.8 0.5 0.3 0.3 0.4 0.2 2.1 1.4 1.4 0.5 0.6 1.0 0.8 1.0 0.5 1.1 1.5 0.5 0.8 0.2 0.8 1.0 0.9 0.8 4.1 1.1 9.5 2.2 0.7 3.8 2.7 0.7 0.6 2.3 2.3 0.5 0.5 0.5 1.0 0.3 0.5 2.0 2.9 0.0 1.7 1.3 0.3 0.1 0.8 2.8 1.3 0.2 0.1 1.4 1.0 0.9 0.8 4.3 1.5 0.3 1.6 1.1 0.3 2.2 0.4 0.0 0.9 1.0 0.5 0.5 0.4 0.9 0.4 2.1 1.2 0.8 0.1 1.4 0.4 1.0 1.0 0.4 2.1 4.8 2.9 1.0 2.7 3.3 1.0 1.1 17.1 2.2 6.0 3.4 0.0 1.6 0.0 3.9 0.4 0.0 397.5 38.7 8.7 7.9 1.4 8.3 2.0 589.3 0.6 0.0 0.0 0.6 0.4 0.7 1.4 1.1 0.9 0.4 1.6 0.0 1.8 0.0 341.5 7.8 0.6 0.0 1.8 0.1 3.4 1.2 0.0 5.3 14.3 8.3 6.5 0.0 416.0 28.2 0.0 0.6 0.0 0.3 0.9 CHMP1B "C18orf2, CHMP1.5, Vps46B" ENSG00000255112 "Charged multivesicular body protein 1B" Q7LBR1 18 11851396-11854449 "Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "skeletal muscle: 250.9" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 450.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061997, HPA062896" Supported Supported Nucleoplasm,Midbody Yes No "Nucleoplasm, Midbody" "HPA061997: AB_2684653, HPA062896: AB_2684898" "unprognostic (6.73e-2)" "unprognostic (5.35e-2)" "unprognostic (1.09e-2)" "unprognostic (6.74e-3)" "unprognostic (1.80e-1)" "unprognostic (1.35e-3)" "unprognostic (1.44e-1)" "unprognostic (8.44e-3)" "unprognostic (1.90e-1)" "unprognostic (9.44e-3)" "unprognostic (2.37e-3)" "unprognostic (9.20e-2)" "prognostic favorable (7.37e-8)" "unprognostic (1.88e-2)" "unprognostic (1.59e-1)" "unprognostic (2.53e-2)" "unprognostic (1.92e-1)" 16.0 13.6 14.9 12.5 11.6 19.5 13.3 8.8 16.0 10.1 14.1 10.0 13.8 14.0 10.4 14.7 14.5 9.1 14.6 17.0 11.2 12.3 12.2 11.2 11.3 14.0 11.6 11.9 11.3 11.2 9.7 12.4 11.8 12.1 10.3 14.1 9.4 12.6 29.5 250.9 15.2 20.4 11.6 13.8 11.3 12.8 6.8 10.0 14.2 19.9 19.4 9.9 14.3 10.1 6.7 13.1 34.4 16.5 7.4 9.1 10.6 12.3 12.1 15.7 13.3 20.6 14.5 22.8 13.2 22.4 9.0 12.1 15.6 12.4 7.7 19.9 14.3 15.1 10.6 7.1 18.4 8.1 7.1 8.8 5.5 18.5 12.8 15.3 21.2 9.6 21.0 39.9 10.1 23.5 20.3 13.0 17.6 9.4 10.0 14.2 15.3 14.6 16.3 6.6 39.4 6.1 7.5 8.1 13.1 24.1 17.0 15.3 15.3 22.5 10.6 20.2 15.3 8.6 19.6 19.0 20.3 10.7 16.0 14.1 12.0 13.7 9.8 18.8 9.9 9.6 10.9 16.5 27.7 7.2 15.3 6.6 6.5 6.7 8.5 13.1 6.7 8.4 7.7 34.4 7.4 15.0 11.7 9.1 10.6 14.9 11.6 8.8 16.0 11.2 12.3 11.6 11.9 12.1 10.0 62.5 46.0 82.1 114.0 372.7 31.1 17.9 56.0 44.2 44.3 125.6 7.9 122.5 51.4 101.8 65.5 63.6 178.4 0.0 71.3 124.5 68.5 78.7 149.7 34.7 112.4 27.0 137.9 43.0 124.4 36.5 35.1 124.4 150.1 100.0 90.8 29.6 115.6 199.9 35.0 109.2 14.1 77.6 64.8 16.4 20.6 450.0 211.8 80.6 63.8 219.0 CHMP5 "C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60" ENSG00000086065 "Charged multivesicular body protein 5" Q9NZZ3 9 33264879-33282069 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033874, HPA042883, HPA056437" Enhanced Supported Microtubules,Midbody,Cytosol Yes No "Microtubules, Cytosol" Midbody "CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (9.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.32e-1)" "unprognostic (4.56e-2)" "unprognostic (3.87e-2)" "unprognostic (2.18e-2)" "unprognostic (4.71e-2)" "unprognostic (2.14e-3)" "unprognostic (7.94e-2)" "unprognostic (2.66e-1)" "prognostic favorable (2.87e-7)" "unprognostic (2.22e-1)" "unprognostic (9.59e-2)" "unprognostic (1.73e-1)" "unprognostic (7.31e-2)" 29.7 37.5 48.0 24.3 48.6 18.8 36.2 39.9 49.4 28.3 39.0 28.1 28.4 38.1 28.2 36.3 39.2 31.4 30.6 35.1 45.1 45.2 55.6 39.2 35.6 26.1 44.1 47.5 26.5 19.9 36.4 34.8 55.7 47.4 40.8 40.9 19.8 26.0 30.2 27.1 25.6 51.9 27.5 49.2 33.0 37.3 21.2 37.0 24.9 42.0 26.1 26.0 33.7 33.5 12.4 27.8 51.2 24.6 18.1 16.6 18.1 31.3 23.4 23.8 15.4 36.4 33.2 22.2 31.4 35.5 50.0 55.6 17.7 19.9 16.9 34.7 29.5 34.3 13.6 24.9 25.6 40.6 35.0 17.5 14.2 47.2 19.3 31.7 18.0 28.0 35.3 47.4 33.6 31.4 41.2 26.0 23.9 15.2 22.4 39.4 14.3 18.6 55.7 21.9 24.1 28.8 11.5 21.1 11.2 41.1 17.1 11.7 30.0 31.8 18.8 28.7 29.1 19.2 28.4 25.9 25.1 26.2 21.4 27.7 14.9 29.6 19.5 36.1 12.4 16.0 31.5 20.1 40.2 10.7 21.6 11.5 12.4 14.3 14.0 18.3 10.6 13.2 12.5 51.2 18.1 24.6 27.8 16.6 18.1 48.0 48.6 39.9 49.4 45.1 45.2 44.1 47.5 47.4 37.0 83.4 48.3 59.3 129.0 167.0 61.8 57.1 91.7 144.6 67.1 104.7 25.5 150.8 242.1 116.7 177.9 132.6 173.1 93.5 75.7 146.8 116.0 157.2 58.7 60.2 136.7 25.4 77.0 73.1 86.4 27.4 86.3 96.9 111.3 216.4 117.4 120.4 122.7 207.0 98.3 256.7 46.8 84.1 128.8 87.4 65.0 206.5 216.6 61.2 74.2 224.1 CPEB3 KIAA0940 ENSG00000107864 "Cytoplasmic polyadenylation element binding protein 3" Q8NE35 10 92046692-92291087 "Predicted intracellular proteins" "Translation regulation" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.4;liver: 39.5" "Group enriched" "Detected in many" 4 "Early spermatids: 216.8;Late spermatids: 321.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 16.1;U-266/70: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070942 Approved "Nucleoplasm,Plasma membrane,Midbody,Cytosol" NA No Cytosol "Nucleoplasm, Plasma membrane, Midbody" "HPA070942: " "unprognostic (4.90e-2)" "unprognostic (2.12e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "unprognostic (1.92e-1)" "unprognostic (2.95e-5)" "prognostic favorable (5.06e-5)" "unprognostic (4.09e-4)" "unprognostic (2.73e-1)" "unprognostic (2.40e-1)" "unprognostic (1.47e-2)" "unprognostic (2.42e-2)" "prognostic favorable (3.84e-9)" "unprognostic (3.33e-2)" "unprognostic (7.42e-2)" "unprognostic (1.36e-2)" "unprognostic (1.40e-1)" 3.1 6.1 11.9 3.0 10.9 2.9 5.0 33.4 24.6 4.0 3.8 4.4 5.5 4.8 3.3 6.8 6.0 3.3 3.4 7.0 10.7 11.5 7.0 39.5 3.6 3.0 10.3 15.1 5.8 5.4 6.6 8.6 2.8 16.4 6.5 4.2 3.0 10.2 8.0 23.4 5.3 4.6 3.4 4.6 4.1 4.5 20.5 7.0 0.3 9.3 5.4 3.4 3.3 4.5 1.8 0.9 6.5 1.5 0.5 0.7 0.5 1.2 0.3 0.4 2.7 0.7 0.7 1.1 1.2 0.9 1.7 1.4 0.9 2.7 1.4 1.3 0.5 0.8 3.4 1.1 0.9 0.9 1.6 1.4 1.9 1.8 1.0 2.0 0.9 2.0 0.7 2.1 1.0 3.1 1.5 1.5 1.9 1.3 16.1 0.7 0.9 1.2 1.1 0.2 1.8 1.3 1.6 2.3 2.8 1.6 0.5 2.0 0.7 1.1 3.1 2.0 1.4 3.9 2.0 1.2 0.8 0.9 0.6 1.0 9.0 2.4 1.5 0.4 3.0 0.2 6.5 1.1 2.2 0.7 1.4 0.5 1.8 0.4 0.7 0.9 0.5 0.4 0.4 1.3 0.5 1.5 0.6 0.3 0.5 11.9 10.9 33.4 24.6 10.7 11.5 10.3 15.1 16.4 7.0 6.0 6.5 0.8 3.2 7.8 25.2 21.8 5.1 2.7 3.4 12.2 47.1 1.8 5.0 2.1 216.8 6.0 7.5 0.0 2.3 1.3 3.9 15.1 3.5 66.1 4.2 28.6 19.0 11.6 22.6 321.1 5.5 7.7 5.0 6.4 9.1 2.5 3.1 3.5 7.4 2.5 21.8 0.0 3.1 11.2 6.8 12.2 1.0 2.5 5.2 5.3 CYSRT1 "C9orf169, MGC59937" ENSG00000197191 "Cysteine rich tail 1" 9 137224635-137226311 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "esophagus: 33.4" "Cell type enriched" "Detected in some" 6 "Pancreatic endocrine cells: 33.8" "Cancer enhanced" "Detected in all" "head and neck cancer: 23.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 3.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 10.0;CAPAN-2: 12.7;HaCaT: 14.1;HeLa: 12.5;MCF7: 19.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021883, HPA021886" Approved Approved "Nuclear speckles,Vesicles,Midbody" Yes No "Nuclear speckles" "Vesicles, Midbody" "HPA021883: AB_1853190, HPA021886: AB_1853192" "unprognostic (1.35e-1)" "unprognostic (2.53e-2)" "unprognostic (8.31e-3)" "unprognostic (6.87e-3)" "unprognostic (2.14e-1)" "unprognostic (2.66e-2)" "unprognostic (8.11e-2)" "unprognostic (5.86e-2)" "unprognostic (3.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (6.24e-3)" "unprognostic (7.92e-3)" "unprognostic (1.99e-1)" "unprognostic (1.03e-1)" "unprognostic (2.29e-1)" 0.7 0.4 1.0 0.7 0.9 0.2 0.8 0.7 1.7 1.4 0.7 0.7 0.7 0.3 0.7 0.7 33.4 1.0 0.7 0.7 1.4 1.3 1.4 0.7 0.7 0.7 0.8 0.7 0.7 0.7 0.3 3.5 0.7 0.7 1.1 0.0 0.7 2.2 0.7 0.7 8.1 0.7 0.7 0.7 0.7 0.8 2.2 0.7 0.7 1.3 0.7 5.3 0.7 2.1 0.9 0.6 0.9 3.0 0.9 0.3 0.1 10.0 1.2 1.0 2.1 0.0 0.1 2.8 0.3 0.3 0.4 0.2 0.7 12.7 0.7 0.8 0.2 0.4 14.1 0.3 3.2 0.0 1.3 1.0 0.2 12.5 6.6 0.7 0.1 0.6 0.3 1.5 0.4 0.1 0.7 0.1 1.0 0.4 2.2 0.8 19.6 0.4 0.7 0.5 2.0 1.5 1.5 1.3 1.7 0.5 0.7 0.3 1.0 2.1 1.8 0.5 0.7 4.0 0.2 0.5 0.8 0.5 1.8 0.3 1.2 0.9 0.7 0.8 0.6 0.8 0.9 0.2 0.2 0.3 1.7 0.1 0.9 0.3 0.2 0.6 0.8 0.2 0.3 0.7 0.9 3.0 0.4 0.2 0.1 1.0 0.9 0.7 1.7 1.4 1.3 0.8 0.7 0.7 0.7 0.0 0.6 0.0 0.2 0.0 0.1 0.2 0.0 0.0 4.5 5.2 0.0 0.4 0.0 1.1 0.5 0.0 0.4 0.0 5.1 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 33.8 0.0 0.4 0.5 0.5 0.0 0.2 1.9 0.3 0.0 0.0 0.0 0.2 1.1 DEFA5 "DEF5, HD-5" ENSG00000164816 "Defensin alpha 5" Q01523 8 7055304-7056734 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 231 "intestine: 574.2" "Group enriched" "Detected in some" 4 "Enterocytes: 16.2;granulocytes: 4.6;Intestinal endocrine cells: 13.6;Mucus-secreting cells: 13.7;Paneth cells: 11.5" "Cancer enhanced" "Detected in many" "cervical cancer: 181.1;colorectal cancer: 147.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BEWO: 19.9;NB-4: 16.4;RPMI-8226: 17.2;SH-SY5Y: 14.0;U-2197: 6.0" "HPA015309, HPA015775, CAB069919" Enhanced Approved Vesicles,Midbody "Secreted to digestive system" NA NA Vesicles Midbody "CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594" "prognostic favorable (9.44e-5)" "unprognostic (3.91e-2)" 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 408.9 0.0 0.0 249.9 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.1 574.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 1.8 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 2.8 0.1 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.7 0.0 DLGAP3 "DAP3, SAPAP3" ENSG00000116544 "DLG associated protein 3" O95886 1 34865436-34929585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 28.7" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 11.5;Hofbauer cells: 7.8;Horizontal cells: 20.6;Late spermatids: 13.7" "Group enriched" "Detected in some" 5 "endometrial cancer: 1.0;glioma: 1.5;ovarian cancer: 1.9;testis cancer: 5.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 9.6;NTERA-2: 5.2;SCLC-21H: 15.5;SH-SY5Y: 3.0" "Group enriched" "Detected in all" 4 "amygdala: 128.4;basal ganglia: 124.0;cerebral cortex: 122.6;hippocampal formation: 84.0;thalamus: 55.9" "Low region specificity" "Detected in all" "HPA026445, HPA027304" Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Midbody" NA NA "Endoplasmic reticulum" "Plasma membrane, Midbody" "HPA026445: AB_1847733, HPA027304: " "unprognostic (8.63e-2)" "unprognostic (8.58e-2)" "unprognostic (1.48e-1)" "unprognostic (5.77e-7)" "unprognostic (4.01e-2)" "unprognostic (5.51e-2)" "unprognostic (2.95e-2)" "unprognostic (8.78e-2)" "unprognostic (2.66e-1)" "unprognostic (1.69e-1)" "unprognostic (1.27e-4)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (6.12e-2)" "unprognostic (1.47e-1)" "unprognostic (2.26e-1)" "unprognostic (2.21e-1)" 1.3 1.5 17.4 1.8 20.0 2.8 1.1 14.6 28.7 0.9 1.2 3.3 0.0 1.4 1.0 1.0 0.9 1.0 1.1 1.0 17.7 5.5 1.3 1.0 1.1 1.4 5.4 9.6 1.0 2.2 1.0 1.9 1.0 2.3 1.0 1.0 0.7 1.1 1.5 1.0 1.1 1.3 1.0 1.1 2.5 1.3 6.7 5.0 0.0 1.0 0.0 1.2 1.0 0.0 0.3 3.2 0.4 2.3 0.1 0.8 0.9 0.1 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 9.6 0.2 0.0 1.2 0.0 1.6 0.0 0.0 0.2 0.2 0.7 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 1.6 0.0 0.0 5.2 0.0 0.0 0.5 0.0 0.2 0.0 0.5 15.5 3.0 0.1 0.1 0.0 0.2 0.3 0.1 0.1 0.1 1.7 0.0 0.0 0.2 0.3 1.9 0.1 0.1 0.1 0.4 2.3 0.0 0.2 1.4 0.8 0.3 0.5 0.5 3.2 0.3 0.2 0.8 0.0 0.1 0.1 0.9 0.7 0.9 17.4 20.0 14.6 22.4 17.7 5.5 5.4 9.6 2.3 5.0 0.0 0.0 0.0 0.6 0.2 4.0 1.1 0.0 0.0 0.0 1.8 3.9 0.1 3.3 0.4 11.5 0.1 0.8 0.0 0.5 0.2 0.2 0.2 0.0 0.0 7.8 20.6 1.2 0.0 7.3 13.7 0.9 1.0 0.0 0.0 0.2 1.3 0.3 0.0 0.0 0.7 2.2 0.0 0.1 2.7 3.4 0.3 0.0 0.8 0.7 0.1 DTNBP1 "BLOC1S8, DBND, Dysbindin, HPS7, My031" ENSG00000047579 "Dystrobrevin binding protein 1" Q96EV8 6 15522801-15663058 "Disease related genes, Predicted intracellular proteins" "Sensory transduction" "Albinism, Hermansky-Pudlak syndrome, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 91.0" "Cell type enhanced" "Detected in many" 6 "Rod photoreceptor cells: 136.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028053, HPA029615, HPA029616" Approved Enhanced Microtubules,Midbody Yes No Microtubules Midbody "HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413" "unprognostic (2.83e-1)" "prognostic favorable (2.82e-4)" "unprognostic (1.62e-1)" "unprognostic (1.20e-1)" "unprognostic (4.93e-2)" "unprognostic (1.29e-2)" "prognostic unfavorable (8.72e-4)" "prognostic favorable (6.34e-5)" "unprognostic (1.36e-1)" "unprognostic (4.28e-3)" "unprognostic (2.21e-3)" "unprognostic (2.08e-1)" "unprognostic (1.88e-2)" "unprognostic (1.37e-1)" "unprognostic (1.75e-1)" "unprognostic (8.81e-3)" "unprognostic (1.09e-2)" 7.2 5.0 22.8 10.5 91.0 9.3 7.7 6.7 18.4 6.8 10.5 7.8 4.5 7.2 8.0 12.5 7.2 6.9 7.9 12.0 15.0 18.0 11.3 5.0 8.4 16.9 18.5 10.3 7.3 6.7 13.1 8.5 9.3 13.7 8.1 10.9 13.4 6.7 10.1 15.4 7.1 7.6 11.9 9.4 10.2 7.6 5.5 17.2 9.3 7.8 2.7 19.4 8.6 8.1 17.8 17.9 8.1 7.1 26.9 12.1 6.6 15.8 6.9 5.9 12.7 8.7 9.9 9.1 8.2 10.7 19.7 17.9 9.1 7.4 22.5 22.1 11.6 16.3 5.5 11.6 8.7 18.0 14.4 15.5 15.8 9.0 13.5 15.2 15.9 13.5 9.4 13.4 10.0 14.9 9.0 17.3 15.5 14.9 5.6 11.8 18.6 16.5 25.3 4.1 13.5 10.0 19.6 11.6 17.5 18.4 16.6 12.1 5.1 6.4 15.4 19.3 14.3 11.1 10.2 7.9 11.2 7.3 11.5 15.0 15.1 28.9 15.8 5.2 14.1 21.1 5.9 5.9 8.1 12.1 7.1 8.0 13.7 10.3 10.4 6.4 17.8 9.8 7.9 6.8 26.9 4.9 17.9 6.9 6.6 22.8 91.0 6.7 18.4 15.0 18.0 18.5 10.3 13.7 17.2 11.9 9.9 44.3 12.8 25.8 42.2 26.6 17.8 9.4 6.8 14.0 55.0 37.3 31.5 32.0 38.0 30.8 18.0 0.0 31.0 15.5 19.0 10.2 54.2 4.5 46.0 23.8 13.3 16.0 15.1 14.5 9.5 25.1 35.4 33.3 15.2 31.7 24.9 8.6 14.5 53.8 136.7 6.5 24.2 17.4 12.7 19.3 14.0 27.9 17.5 9.3 FAM50B "D6S2654E, X5L" ENSG00000145945 "Family with sequence similarity 50 member B" Q9Y247 6 3849386-3851317 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 42.6;MCF7: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA064111, HPA067817" Approved Enhanced "Nucleoplasm,Cytokinetic bridge,Midbody" Yes NA Nucleoplasm "Cytokinetic bridge, Midbody" "HPA064111: AB_2685191, HPA067817: AB_2685904" "unprognostic (1.15e-1)" "unprognostic (7.76e-2)" "unprognostic (4.28e-2)" "unprognostic (4.43e-2)" "unprognostic (2.12e-3)" "unprognostic (2.69e-1)" "unprognostic (2.38e-2)" "unprognostic (7.13e-2)" "unprognostic (1.60e-1)" "unprognostic (1.79e-1)" "unprognostic (2.15e-1)" "unprognostic (2.90e-1)" "prognostic favorable (4.01e-6)" "unprognostic (1.60e-1)" "unprognostic (3.22e-1)" "unprognostic (1.34e-1)" "unprognostic (9.39e-2)" 7.2 9.5 13.4 5.7 20.6 3.1 5.7 18.7 16.7 6.7 6.8 11.0 8.4 10.1 8.3 6.7 5.5 11.2 8.1 16.0 12.8 14.2 12.9 12.0 6.2 7.1 11.4 14.9 14.4 12.7 5.8 7.7 3.4 9.7 8.2 3.0 5.9 15.2 9.8 41.1 7.9 6.9 10.2 10.8 7.7 7.9 10.2 9.9 5.8 11.8 5.7 5.5 7.5 13.3 14.9 10.1 3.4 9.1 19.4 20.5 5.6 3.1 4.3 0.0 0.0 2.6 2.4 0.2 3.8 1.8 2.6 3.3 0.0 5.9 3.4 4.1 2.7 1.0 2.4 0.0 1.5 1.9 42.6 2.3 0.0 10.2 0.0 2.7 0.0 0.0 2.7 3.0 2.0 0.6 0.8 2.6 0.0 0.0 0.0 2.3 13.4 0.0 4.7 0.9 2.0 2.0 0.0 0.0 0.0 1.2 0.0 6.0 5.3 6.2 3.9 0.2 0.0 4.2 3.8 3.5 0.0 0.4 5.1 0.0 0.0 9.2 0.0 1.4 0.3 7.1 3.4 4.7 2.4 7.1 6.1 16.8 14.9 13.6 9.2 6.1 12.9 11.3 7.1 1.9 19.4 9.1 10.1 20.5 5.6 13.4 20.6 18.7 16.7 12.8 14.2 11.4 14.9 9.7 9.9 14.9 6.5 6.5 5.9 5.7 17.4 15.7 5.1 4.0 7.9 12.2 3.9 3.3 28.2 10.7 24.9 4.1 2.2 0.0 9.9 4.8 5.8 2.7 3.5 18.8 8.7 14.3 1.2 8.6 4.1 25.0 7.8 4.0 11.8 10.0 3.3 19.1 7.9 3.6 10.3 32.6 12.6 0.0 7.9 34.4 39.6 5.8 0.8 4.5 3.3 1.6 INCENP FLJ31633 ENSG00000149503 "Inner centromere protein" Q9NQS7 11 62123973-62153163 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.1" "Cell type enhanced" "Detected in many" 4 "monocytes: 8.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 2.9;NK-cell: 4.0" "Group enriched" "Detected in many" 6 "granulocytes: 2.9;NK-cells: 4.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013292, HPA051339, HPA070550" Enhanced Supported "Nucleoplasm,Nuclear bodies,Kinetochore,Midbody" Yes Yes "Nuclear bodies, Kinetochore" "Nucleoplasm, Midbody" "CAB013292: AB_2533405, HPA051339: AB_2732566, HPA070550: AB_2686279" "unprognostic (6.31e-2)" "unprognostic (7.29e-2)" "unprognostic (1.65e-3)" "unprognostic (7.35e-2)" "unprognostic (3.18e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.25e-4)" "prognostic unfavorable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (4.37e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (1.74e-2)" "unprognostic (1.08e-3)" "unprognostic (1.17e-3)" "unprognostic (1.22e-1)" "unprognostic (1.36e-1)" "unprognostic (2.78e-3)" 5.1 5.0 6.9 9.2 8.2 23.8 7.7 19.3 13.6 6.9 6.5 5.7 2.8 9.5 5.7 11.7 22.2 5.3 4.7 4.1 5.9 5.0 3.9 3.8 5.0 14.1 6.9 7.9 5.3 5.4 6.0 3.1 5.7 6.9 4.2 5.3 4.9 10.6 4.6 6.7 9.8 7.5 4.9 5.1 7.5 6.4 12.3 6.4 36.1 8.5 8.5 13.2 5.9 8.6 0.2 0.0 2.9 0.3 4.0 0.5 0.0 27.0 25.9 19.7 16.8 2.6 3.2 10.5 17.0 7.4 15.9 10.2 13.6 18.4 25.1 14.1 5.8 17.6 26.6 19.5 10.3 12.5 22.3 13.5 16.4 25.5 11.1 1.0 18.8 23.4 1.6 2.3 15.3 8.9 2.6 9.5 18.3 17.3 21.0 8.7 22.0 30.3 15.4 21.2 10.5 12.7 28.4 24.8 18.9 4.5 13.6 15.0 16.3 17.1 11.1 10.5 8.2 17.4 6.8 10.6 15.7 20.1 22.4 18.1 11.2 17.2 28.2 8.7 12.4 18.8 2.9 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.2 4.0 0.1 0.0 0.0 0.0 6.9 8.2 19.3 13.6 5.9 5.0 6.9 7.9 6.9 6.4 3.0 2.9 2.2 0.8 4.9 1.9 0.9 0.0 4.0 5.7 0.0 0.0 1.6 0.0 1.7 0.8 0.8 1.3 0.0 2.1 6.0 0.8 1.0 3.5 0.9 3.5 0.0 0.0 0.0 0.8 0.2 2.6 2.5 3.3 8.2 2.0 2.3 1.7 1.5 1.4 0.3 2.2 0.0 0.4 6.9 5.8 2.9 1.8 2.5 1.7 1.0 KATNBL1 "C15orf29, FLJ22557" ENSG00000134152 "Katanin regulatory subunit B1 like 1" Q9H079 15 34140674-34210096 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 75.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 46.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 46.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062573 Approved Supported "Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle" Yes No "Midbody, Mitotic spindle" "Nucleoplasm, Cleavage furrow" "HPA062573: AB_2684796" "unprognostic (5.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.35e-2)" "unprognostic (2.91e-2)" "unprognostic (2.01e-2)" "unprognostic (1.38e-1)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.01e-1)" "unprognostic (5.16e-2)" "unprognostic (3.94e-3)" "unprognostic (8.00e-3)" "prognostic unfavorable (4.60e-5)" "unprognostic (2.71e-2)" "unprognostic (7.23e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" 13.2 7.9 16.2 14.0 22.6 9.1 22.7 16.7 26.0 11.7 12.2 10.7 10.5 9.6 13.5 12.5 28.8 10.9 10.2 9.0 11.2 9.0 9.1 10.9 20.2 10.7 13.8 10.3 10.9 14.3 8.7 10.4 75.0 15.0 11.9 13.6 8.9 10.5 9.0 7.4 19.7 9.4 16.1 17.8 12.0 11.0 11.0 12.8 7.5 8.3 8.6 12.3 10.2 19.1 9.1 10.2 46.0 6.8 4.3 8.9 4.5 17.7 15.6 24.9 16.6 20.2 20.2 18.5 24.2 14.7 19.4 19.4 8.8 9.9 8.7 15.9 15.7 27.4 23.5 12.1 13.9 23.0 17.8 6.5 15.3 16.5 10.4 14.0 16.0 16.7 12.0 20.5 13.1 26.0 20.2 34.7 22.4 16.3 18.3 26.4 8.7 10.0 13.2 18.2 22.9 12.4 15.5 15.1 8.1 17.9 24.0 14.1 12.6 14.8 10.9 7.1 25.8 13.5 19.2 19.9 26.4 13.6 23.4 19.1 11.4 15.3 17.9 23.7 17.5 19.6 16.5 6.8 10.3 7.0 6.3 8.9 8.5 7.7 7.2 7.4 9.1 8.6 7.6 46.0 4.3 4.0 10.2 6.3 4.5 16.2 22.6 16.7 26.0 11.2 9.0 13.8 10.3 15.0 12.8 35.7 25.1 24.1 50.0 36.7 53.1 11.8 28.1 44.2 34.2 24.4 49.1 52.9 28.2 51.7 63.2 41.9 19.0 0.0 47.3 69.4 32.9 72.1 42.8 18.4 34.4 63.5 23.0 32.5 28.5 42.2 29.4 37.7 30.4 56.9 30.5 52.5 80.0 38.6 31.1 34.2 40.0 58.2 43.0 37.0 44.8 47.4 150.1 31.6 35.9 104.3 KCNB2 Kv2.2 ENSG00000182674 "Potassium voltage-gated channel subfamily B member 2" Q92953 8 72537391-72938349 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2" "Cell type enriched" "Detected in some" 15 "Cone photoreceptor cells: 249.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 3.2;HDLM-2: 3.1;HEK 293: 7.6;SCLC-21H: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065970 Approved "Nucleoli,Plasma membrane,Midbody" Yes NA "Plasma membrane" "Nucleoli, Midbody" "HPA065970: AB_2685591" "unprognostic (9.87e-3)" "unprognostic (1.71e-1)" "unprognostic (7.57e-2)" "unprognostic (1.10e-3)" "unprognostic (1.22e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (2.72e-1)" "unprognostic (6.93e-5)" "unprognostic (5.53e-3)" "unprognostic (3.30e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-2)" "unprognostic (3.26e-1)" 0.8 1.9 3.8 0.6 5.3 0.4 0.7 0.3 9.7 0.5 0.7 0.0 0.0 1.2 0.4 0.4 1.1 2.1 0.5 0.4 7.1 3.1 0.5 0.4 0.6 0.5 0.9 7.8 0.4 2.4 0.4 9.2 0.5 3.2 0.7 0.7 4.2 0.5 0.5 0.4 0.4 1.6 0.5 1.6 8.6 2.4 1.7 0.4 0.9 0.4 0.0 0.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 5.3 0.3 9.7 7.1 3.1 0.9 7.8 3.2 0.4 0.0 0.0 0.0 0.0 0.0 12.9 0.2 0.0 0.0 0.0 1.8 249.4 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 17.1 0.0 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.4 0.0 2.4 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 KIF20B "CT90, KRMP1, MPHOSPH1, MPP1" ENSG00000138182 "Kinesin family member 20B" Q96Q89 10 89701610-89774939 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.2" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 149.9;Spermatogonia: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA050214 Supported Supported "Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol" Yes Yes "Nucleoplasm, Cytokinetic bridge" "Midbody, Cytosol" "HPA050214: AB_2681053" "unprognostic (2.13e-1)" "unprognostic (3.01e-2)" "unprognostic (1.72e-2)" "unprognostic (3.20e-2)" "unprognostic (2.65e-1)" "unprognostic (7.39e-2)" "unprognostic (8.95e-5)" "unprognostic (3.32e-3)" "unprognostic (2.01e-2)" "unprognostic (8.14e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.62e-2)" "prognostic unfavorable (3.06e-6)" "unprognostic (4.22e-3)" "unprognostic (2.70e-1)" "unprognostic (2.51e-2)" "unprognostic (6.43e-2)" 3.9 2.3 1.3 5.9 6.6 11.1 3.2 12.8 3.0 4.1 3.8 0.7 1.1 4.3 3.4 2.2 7.0 3.3 1.5 2.2 2.1 1.3 2.4 3.2 2.8 9.5 1.6 2.6 4.3 2.0 2.1 3.2 4.0 3.6 2.3 5.1 1.5 3.4 2.0 2.1 4.9 5.5 3.0 3.0 8.0 3.0 10.2 2.6 26.2 2.8 3.9 9.1 2.8 3.8 13.3 4.8 8.3 3.9 2.4 8.6 1.9 36.0 7.4 10.8 9.6 2.1 3.7 9.0 14.8 13.6 15.6 16.4 9.7 16.7 14.0 4.7 7.5 5.8 18.4 12.0 8.3 21.0 16.8 8.2 14.2 12.9 8.4 0.6 24.1 11.8 1.5 1.2 15.0 15.4 5.5 10.0 7.4 13.5 16.2 13.8 6.2 14.1 4.6 11.1 5.9 7.1 9.8 21.3 6.1 4.8 4.8 3.4 6.2 10.6 4.8 5.6 8.1 12.6 7.0 7.8 10.0 10.1 13.0 23.8 4.5 12.2 18.8 9.5 21.5 7.4 8.3 2.3 3.7 5.5 3.9 6.7 11.5 7.4 5.9 1.2 13.3 8.6 8.0 0.1 2.4 3.8 4.8 8.6 1.9 1.3 6.6 12.8 3.0 2.1 1.3 1.6 2.6 3.6 2.6 3.0 15.7 46.6 7.4 15.8 11.8 7.1 2.5 6.7 7.9 0.0 9.8 9.8 3.3 5.1 8.6 7.8 5.9 70.0 4.0 30.5 12.7 3.4 43.8 3.8 17.2 12.7 1.2 8.6 11.6 9.6 7.5 16.4 5.0 9.0 5.4 6.4 2.9 5.7 8.1 2.4 9.1 6.5 15.5 149.9 96.9 12.3 4.3 26.1 13.0 2.2 KIF2C "CT139, KNSL6, MCAK" ENSG00000142945 "Kinesin family member 2C" Q99661 1 44739818-44767767 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.9;testis: 61.4" "Group enriched" "Detected in many" 18 "Early spermatids: 430.2;Late spermatids: 1559.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA006219, HPA079172" Enhanced Supported Nucleoplasm,Midbody,Centrosome Yes Yes "Nucleoplasm, Centrosome" Midbody "HPA006219: AB_2667540, HPA079172: " "unprognostic (3.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.77e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (3.07e-7)" "unprognostic (7.49e-3)" "unprognostic (3.33e-3)" "unprognostic (3.66e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (4.27e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.33e-3)" "unprognostic (1.49e-1)" "unprognostic (1.86e-2)" "unprognostic (2.41e-1)" 1.1 0.7 0.4 8.7 0.4 12.7 0.8 0.5 0.5 1.2 2.4 0.4 0.2 2.1 1.3 1.4 4.6 0.6 0.7 0.9 0.6 0.5 0.7 0.6 1.6 6.7 0.4 0.2 0.7 0.4 0.3 0.6 2.2 0.6 0.6 3.2 0.4 1.1 0.2 0.4 2.3 2.2 1.1 0.4 3.3 1.4 61.4 0.2 39.9 0.8 4.7 12.0 0.9 1.7 1.3 1.5 0.0 0.2 3.9 5.8 1.0 29.0 11.3 25.3 20.2 1.4 2.9 17.0 21.8 15.6 44.7 39.0 19.1 21.1 33.5 10.5 10.7 30.9 13.9 25.7 14.7 40.9 21.6 11.1 39.6 20.0 15.9 0.1 29.2 18.4 0.7 1.4 31.8 15.6 4.1 14.4 23.8 31.2 28.8 28.2 11.3 30.7 17.7 24.7 14.3 14.2 24.7 38.2 21.0 7.5 10.6 17.4 12.4 29.0 20.7 18.3 19.1 11.9 22.2 8.5 16.2 32.3 17.6 38.2 15.2 15.5 48.3 10.4 28.5 31.2 0.0 0.0 0.0 1.9 0.0 0.1 1.3 3.4 2.6 0.3 0.2 0.7 0.5 0.0 3.9 0.2 1.5 5.8 1.0 0.4 0.4 0.5 0.5 0.6 0.5 0.4 0.2 0.6 0.2 0.0 0.3 0.8 0.5 1.5 1.0 0.8 0.0 0.0 2.3 1.8 2.0 1.1 1.7 0.3 430.2 0.1 0.0 23.3 0.3 20.1 0.7 0.6 0.0 0.0 7.4 0.0 0.0 4.3 1.0 1559.3 8.6 1.3 0.0 7.2 0.9 0.3 0.1 0.0 6.3 0.0 0.2 6.5 0.3 55.1 28.0 0.4 3.1 0.7 1.6 0.4 KIF4A "FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100" ENSG00000090889 "Kinesin family member 4A" O95239 X 70290090-70420832 "Predicted intracellular proteins" "DNA-binding, Motor protein" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.1;lymphoid tissue: 19.3" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Low cell line specificity" "Detected in many" "HPA034745, HPA034746, HPA061583" Approved Supported Nucleoplasm,Midbody Yes Yes "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564" "unprognostic (8.17e-3)" "unprognostic (2.78e-2)" "unprognostic (1.02e-2)" "unprognostic (3.46e-3)" "unprognostic (3.20e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (7.37e-6)" "unprognostic (2.18e-3)" "unprognostic (5.06e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (9.44e-6)" "unprognostic (3.79e-2)" "unprognostic (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (1.47e-1)" 0.9 0.6 0.8 3.3 1.0 11.1 0.5 0.4 3.4 1.2 4.1 0.4 0.4 3.4 0.8 0.4 7.4 1.5 2.5 2.0 0.8 1.3 0.7 0.7 1.5 5.8 0.5 0.9 0.4 0.4 0.0 1.3 2.4 0.8 0.7 5.2 0.4 1.2 0.4 0.8 2.3 3.6 1.2 0.5 4.9 2.1 7.5 1.1 19.3 0.4 0.4 7.2 1.1 2.0 0.7 0.0 0.0 0.2 0.2 3.2 0.3 22.5 15.8 23.9 11.7 1.1 2.0 9.4 17.2 9.2 23.5 20.5 17.7 13.3 13.9 10.8 8.4 18.2 13.6 25.8 9.3 26.6 15.9 13.0 15.7 19.3 12.5 0.2 17.4 10.9 0.7 0.5 19.5 11.2 2.8 14.3 10.7 19.9 30.9 22.1 14.5 15.9 8.6 24.1 24.1 16.8 17.7 32.3 13.0 5.6 8.9 15.8 13.2 28.0 11.9 7.3 12.6 9.5 6.8 9.9 15.6 20.3 16.7 20.4 8.9 15.3 20.1 8.2 19.1 23.4 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 3.2 0.3 0.8 1.0 0.4 3.4 0.8 1.3 0.5 0.9 0.8 1.1 0.0 0.3 0.0 0.2 1.5 0.0 0.4 2.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.1 46.7 0.0 10.3 1.0 0.1 0.0 0.0 4.3 0.0 1.2 1.8 0.6 0.5 0.0 0.9 0.0 0.0 1.2 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 7.2 5.8 0.3 1.5 0.5 2.1 0.3 KIF4B ENSG00000226650 "Kinesin family member 4B" Q2VIQ3 5 155013755-155018132 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 9.0" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 2.0;Early spermatids: 4.7;Late spermatids: 3.1;Spermatocytes: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.4" "HPA034745, HPA034746, HPA061583" Uncertain Uncertain Nucleoplasm,Midbody Yes NA "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564" "unprognostic (9.87e-3)" "unprognostic (1.17e-1)" "unprognostic (3.91e-3)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.71e-1)" "unprognostic (4.76e-2)" "unprognostic (1.94e-1)" "unprognostic (1.06e-1)" "unprognostic (4.37e-2)" "unprognostic (6.48e-9)" "unprognostic (7.24e-2)" "unprognostic (5.10e-2)" "unprognostic (1.71e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.4 0.1 0.0 0.1 0.6 0.0 0.1 0.3 0.0 0.9 0.0 0.5 0.0 0.2 0.5 0.1 0.0 0.1 0.7 0.1 0.4 1.0 0.4 0.0 0.4 0.7 0.0 0.3 0.2 0.0 0.0 1.1 0.6 0.2 2.4 0.4 0.0 0.8 0.5 0.5 0.1 0.5 0.7 1.2 1.0 0.0 0.7 0.5 0.6 1.3 0.2 0.3 0.0 0.5 0.5 0.2 0.8 1.3 0.7 1.2 0.4 0.6 0.5 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 LAP3 "LAP, LAPEP, PEPS" ENSG00000002549 "Leucine aminopeptidase 3" P28838 4 17577192-17607972 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 227.4;monocytes: 251.5;Proximal tubular cells: 217.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029606, HPA029607" Enhanced Supported Nucleoplasm,Midbody,Cytosol Yes No 4100000 Cytosol "Nucleoplasm, Midbody" "HPA029606: AB_10599288, HPA029607: AB_10611381" "unprognostic (2.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (2.87e-1)" "unprognostic (2.16e-1)" "unprognostic (1.55e-1)" "unprognostic (5.33e-2)" "unprognostic (1.44e-3)" "unprognostic (2.61e-3)" "unprognostic (1.17e-1)" "unprognostic (4.29e-3)" "unprognostic (1.73e-1)" "unprognostic (3.28e-2)" "unprognostic (3.06e-1)" "unprognostic (8.79e-2)" 42.5 29.7 23.2 43.9 38.5 18.1 30.7 8.5 23.5 13.3 21.0 23.5 12.3 27.5 17.2 20.8 19.3 18.7 24.3 25.4 24.4 17.0 71.7 70.3 39.4 54.2 33.7 16.1 13.5 14.7 23.5 13.2 25.0 34.9 15.3 22.7 15.0 23.0 12.1 33.3 20.9 30.6 26.9 35.0 54.9 20.8 19.3 30.7 19.9 29.4 21.7 32.1 24.4 23.7 7.5 45.7 9.5 46.1 11.8 12.9 25.3 10.9 9.6 9.2 8.7 18.3 22.3 0.1 17.3 19.5 62.9 76.5 17.5 20.9 43.2 11.5 13.3 37.5 6.8 34.5 12.2 24.0 16.4 9.9 23.9 10.6 22.8 21.3 21.5 15.4 22.7 7.8 20.6 10.9 7.2 21.8 11.4 23.1 30.9 14.8 11.8 19.1 29.5 19.2 20.6 18.4 29.7 8.8 21.8 16.4 12.9 13.6 11.2 15.8 9.8 33.8 13.3 8.3 8.3 14.1 16.0 10.8 16.8 30.0 28.4 43.4 37.3 21.6 35.9 15.4 8.4 43.4 9.5 8.0 46.1 7.4 7.5 7.5 8.5 45.7 5.2 6.5 6.8 6.2 11.8 31.9 25.9 12.9 25.3 23.2 38.5 8.5 23.5 24.4 17.0 33.7 16.1 34.9 30.7 26.8 44.7 44.2 21.0 19.6 8.0 43.2 10.2 46.8 26.1 26.2 2.0 31.2 99.5 46.8 71.4 104.1 38.5 0.0 96.6 44.5 25.9 23.1 63.4 92.3 227.4 6.4 15.6 68.2 96.6 22.8 21.3 135.7 40.5 251.5 30.0 93.7 42.5 30.2 32.9 217.2 12.6 32.3 24.7 46.4 13.2 19.9 46.6 30.5 39.9 21.7 LBX2 ENSG00000179528 "Ladybird homeobox 2" Q6XYB7 2 74497517-74503316 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 13.8" "Cell type enhanced" "Detected in some" 11 "Hepatocytes: 2.8;Ito cells: 2.5;Proximal tubular cells: 6.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 9.3;Hep G2: 19.3;SK-MEL-30: 8.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cerebellum: 1.3;olfactory region: 0.9" HPA044257 Uncertain Approved Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA044257: AB_2678880" "unprognostic (5.24e-2)" "unprognostic (7.97e-2)" "unprognostic (2.35e-5)" "unprognostic (8.22e-4)" "unprognostic (2.95e-1)" "unprognostic (2.94e-1)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (2.02e-1)" "unprognostic (2.76e-2)" "unprognostic (1.85e-1)" "unprognostic (3.25e-2)" "unprognostic (1.43e-5)" "unprognostic (5.77e-2)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (1.87e-2)" 4.4 0.4 1.5 1.0 0.5 0.3 1.3 0.5 0.5 1.1 6.8 0.0 1.5 8.3 2.2 2.6 0.5 0.6 3.9 1.8 0.3 0.3 1.9 13.8 3.7 0.4 0.3 0.6 0.6 3.4 0.0 0.3 2.6 0.5 0.6 0.0 0.2 1.5 0.4 0.8 1.3 7.3 0.1 0.4 1.9 4.9 1.3 0.0 0.3 1.1 1.7 2.1 0.8 0.6 0.2 2.1 1.6 4.8 2.5 1.0 1.5 3.8 1.4 0.0 0.1 1.7 1.4 6.5 0.3 0.2 0.4 0.4 9.3 5.7 0.2 1.6 0.7 0.6 1.5 0.0 0.3 0.0 8.0 1.7 4.1 0.5 19.3 1.3 0.2 2.6 1.8 1.4 1.4 0.3 0.2 1.6 0.1 2.7 2.0 0.3 2.0 0.1 0.8 0.4 1.6 0.2 0.4 0.4 0.2 0.2 1.2 0.2 1.1 2.3 0.3 8.4 0.1 0.2 0.3 3.6 1.4 6.1 7.4 0.1 2.6 2.0 0.2 1.4 0.7 4.3 0.8 4.0 0.3 0.8 1.9 0.5 0.2 0.2 1.0 2.1 0.2 0.2 0.7 1.6 2.5 4.8 0.6 0.1 1.5 1.5 0.5 0.5 0.5 0.3 0.3 0.3 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.5 0.0 0.0 1.6 0.0 0.6 0.4 0.3 0.0 0.0 2.8 0.9 0.0 2.4 2.5 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 6.3 0.0 6.5 0.2 0.0 0.0 0.1 0.5 0.0 0.8 0.1 LYRM1 A211C6.1 ENSG00000102897 "LYR motif containing 1" O43325 16 20899868-20925006 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 101.6" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 144.2;Late spermatids: 327.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059840 Supported Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA059840: AB_2684137" "unprognostic (4.44e-2)" "unprognostic (1.03e-1)" "unprognostic (1.66e-2)" "prognostic favorable (7.48e-7)" "unprognostic (3.04e-1)" "unprognostic (1.10e-1)" "unprognostic (3.47e-1)" "unprognostic (8.60e-2)" "unprognostic (1.20e-1)" "unprognostic (1.04e-2)" "unprognostic (1.49e-2)" "unprognostic (3.39e-1)" "prognostic unfavorable (4.80e-4)" "unprognostic (1.57e-1)" "unprognostic (6.18e-2)" "unprognostic (3.86e-1)" "prognostic favorable (9.50e-4)" 25.4 18.9 19.1 15.0 17.4 12.8 25.5 12.6 17.8 17.5 16.6 9.6 14.0 9.5 17.1 21.1 16.2 24.9 17.0 34.2 15.4 18.2 30.6 101.6 11.2 19.2 18.8 13.8 25.3 26.1 20.5 13.9 9.0 24.9 21.1 14.0 13.1 14.1 19.1 28.7 10.6 12.6 27.6 17.9 11.5 15.7 22.9 9.0 16.2 19.4 14.9 12.9 25.3 19.7 12.7 7.2 47.4 10.2 8.4 14.2 10.1 12.1 13.0 12.1 9.6 32.9 26.2 4.0 10.1 16.9 5.8 8.8 14.6 15.2 8.5 39.5 12.1 8.5 8.5 5.3 10.6 9.5 15.9 8.3 3.9 3.6 37.6 24.5 12.7 7.7 19.0 9.4 16.3 46.8 16.5 24.1 12.7 8.5 15.1 25.2 16.1 12.5 8.6 12.6 18.1 6.9 17.2 6.7 10.2 21.0 7.1 11.9 11.4 6.3 10.5 16.8 7.0 10.8 7.4 6.4 8.4 6.1 13.2 6.9 14.9 20.9 13.3 21.9 13.7 7.3 47.4 7.2 23.3 8.6 9.1 11.8 12.7 13.2 10.6 5.9 11.2 10.7 10.8 26.8 8.4 10.2 7.2 14.2 10.1 19.1 17.4 12.6 17.8 15.4 18.2 18.8 13.8 24.9 9.0 17.9 13.9 29.7 49.4 18.7 29.4 53.1 25.5 24.1 10.3 22.7 13.7 23.9 64.6 36.2 144.2 28.7 7.0 0.0 38.2 7.9 24.2 36.6 15.1 41.4 13.8 14.3 28.8 11.1 11.6 327.6 26.7 12.7 16.9 55.9 15.3 26.4 29.5 14.0 35.7 98.2 27.2 12.9 22.0 66.8 24.3 18.2 12.5 26.1 25.2 44.5 MAPK4 "Erk3-related, Erk4, PRKM4" ENSG00000141639 "Mitogen-activated protein kinase 4" P31152 18 50560078-50731824 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.4;brain: 33.4;parathyroid gland: 43.5" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 20.1;Early spermatids: 20.2;Late spermatids: 42.4;Muller glia cells: 55.0" "Group enriched" "Detected in many" 5 "glioma: 15.2;melanoma: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.0;HeLa: 4.5;NTERA-2: 3.0;SCLC-21H: 15.7;SH-SY5Y: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007461 Approved "Nucleoplasm,Golgi apparatus,Midbody" NA NA "Nucleoplasm, Golgi apparatus" Midbody "HPA007461: AB_1079308" "unprognostic (4.12e-2)" "unprognostic (3.24e-2)" "unprognostic (3.60e-1)" "unprognostic (1.42e-3)" "unprognostic (5.17e-2)" "unprognostic (1.84e-2)" "unprognostic (6.32e-2)" "unprognostic (2.08e-2)" "unprognostic (8.24e-2)" "unprognostic (1.61e-1)" "unprognostic (4.38e-3)" "unprognostic (2.16e-1)" "unprognostic (3.44e-7)" "unprognostic (1.96e-4)" "unprognostic (5.99e-4)" "unprognostic (2.31e-2)" "unprognostic (1.82e-1)" 1.9 26.4 16.9 1.1 33.4 0.9 1.8 15.9 23.9 1.4 2.6 9.5 3.8 1.6 1.8 4.5 3.5 1.5 3.0 16.9 13.0 14.3 4.5 7.0 3.5 0.9 17.1 9.1 4.2 2.5 43.5 8.3 3.7 20.5 5.3 1.8 4.1 1.8 12.4 1.7 1.0 1.9 5.2 11.8 1.1 1.3 3.5 12.4 1.7 7.8 0.0 0.9 2.2 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 1.5 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.9 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 15.7 3.8 0.1 1.1 2.6 0.9 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 33.4 15.9 14.5 13.0 14.3 17.1 9.1 20.5 12.4 8.9 0.0 0.0 0.1 0.0 11.0 20.1 2.5 0.0 0.0 0.0 0.0 3.6 5.0 1.0 20.2 0.0 0.0 0.0 0.0 0.3 0.4 0.8 0.0 0.8 0.3 4.8 0.0 0.0 0.0 42.4 0.9 0.0 0.0 0.0 0.0 55.0 0.5 0.0 1.4 0.0 0.6 0.0 1.0 0.6 0.6 0.0 1.5 0.0 0.0 0.0 MBD5 "FLJ11113, KIAA1461" ENSG00000204406 "Methyl-CpG binding domain protein 5" Q9P267 2 148021011-148516971 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035964 Supported Nucleoplasm,Midbody NA NA "Nucleoplasm, Midbody" "HPA035964: AB_2674891" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.72e-4)" "unprognostic (5.81e-2)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (1.65e-1)" "unprognostic (9.86e-2)" "unprognostic (7.72e-2)" "unprognostic (2.00e-1)" "unprognostic (1.94e-1)" "unprognostic (2.39e-2)" "unprognostic (9.12e-2)" "unprognostic (1.12e-1)" "unprognostic (6.59e-2)" "unprognostic (1.82e-1)" 8.5 11.3 13.9 14.1 13.7 6.8 9.0 26.1 14.7 13.7 16.3 10.1 8.9 7.2 12.6 8.7 9.9 9.6 13.4 10.3 11.7 10.6 13.7 6.9 8.2 8.7 9.3 9.9 14.2 5.7 25.5 24.7 10.4 11.3 11.5 8.1 10.8 7.5 11.6 9.9 6.6 8.2 15.7 11.8 9.8 9.1 11.0 12.5 17.3 12.8 6.0 8.6 15.1 10.1 1.3 1.1 3.6 1.2 1.0 2.2 0.7 1.4 1.5 9.0 6.5 6.5 7.4 4.0 6.7 7.3 4.5 3.8 3.4 4.5 2.5 1.7 5.7 2.2 1.0 4.7 7.4 6.4 2.2 2.2 5.4 4.9 1.7 2.7 0.7 0.8 5.6 6.5 6.0 4.0 9.3 7.5 4.5 2.0 6.1 7.6 3.4 2.9 3.9 3.0 4.0 2.4 2.9 1.5 0.9 6.0 7.2 5.2 7.3 4.3 2.3 4.5 5.5 2.9 4.5 5.5 5.3 2.2 0.7 2.9 4.4 1.7 2.2 9.0 2.5 6.1 3.6 0.4 1.9 1.6 0.3 1.1 0.7 1.8 1.5 0.9 1.3 1.4 2.2 0.6 1.0 1.2 1.1 0.6 0.7 13.9 13.7 26.1 14.7 11.7 10.6 9.3 9.9 11.3 12.5 14.9 10.7 3.9 10.8 3.4 23.3 8.7 12.7 12.0 23.9 12.2 35.3 6.1 3.3 16.7 52.0 9.0 4.6 0.0 13.8 7.3 7.9 8.0 3.5 7.4 6.0 12.7 11.1 11.6 14.9 28.9 16.7 14.6 0.0 10.8 5.5 9.0 16.2 3.5 9.9 11.6 16.8 6.5 5.2 5.1 7.3 2.9 7.1 13.8 6.9 10.7 MED9 "FLJ10193, MED25" ENSG00000141026 "Mediator complex subunit 9" Q9NWA0 17 17476986-17493226 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056415 Uncertain Approved Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA056415: AB_2683120" "unprognostic (1.81e-2)" "unprognostic (4.58e-2)" "unprognostic (2.65e-1)" "unprognostic (3.48e-3)" "unprognostic (1.27e-1)" "unprognostic (2.18e-1)" "unprognostic (1.89e-1)" "unprognostic (3.21e-2)" "unprognostic (4.23e-1)" "unprognostic (7.65e-2)" "prognostic favorable (4.18e-5)" "unprognostic (3.96e-2)" "prognostic favorable (2.83e-9)" "unprognostic (2.26e-3)" "unprognostic (2.29e-1)" "unprognostic (3.09e-1)" "unprognostic (1.39e-1)" 10.2 12.7 16.0 6.5 23.5 12.3 14.1 16.3 29.1 13.0 11.2 9.2 10.9 11.2 11.7 17.3 8.2 11.7 6.6 30.0 14.3 13.6 13.9 19.1 8.2 11.5 13.6 14.5 12.4 10.2 20.3 11.3 7.9 12.6 11.4 10.5 8.9 15.8 14.9 34.4 11.3 10.5 8.6 10.3 9.5 10.1 12.9 8.6 14.9 13.4 15.2 9.1 7.5 7.8 11.4 12.8 11.8 11.4 10.3 13.4 7.4 7.3 9.4 8.1 8.7 6.6 5.9 7.0 6.0 7.4 9.3 8.4 13.7 3.7 9.1 6.9 6.2 5.6 9.6 10.3 8.3 8.8 5.7 16.4 5.5 6.2 9.8 7.0 4.4 4.8 9.6 7.9 7.8 8.1 7.0 6.3 13.3 6.5 4.2 6.2 6.2 19.7 9.1 7.5 15.3 9.7 15.3 18.4 5.9 8.1 5.2 5.3 8.4 7.9 6.3 13.3 32.1 7.4 5.8 4.3 6.9 8.0 11.8 9.4 8.0 5.6 5.0 8.6 7.8 7.2 2.7 7.0 11.8 10.3 9.6 13.4 11.4 10.7 10.6 7.8 10.4 11.6 12.8 2.4 10.3 11.4 12.8 10.3 7.4 16.0 23.5 16.3 29.1 14.3 13.6 13.6 14.5 12.6 8.6 3.0 4.1 0.9 8.0 4.0 14.2 17.7 7.6 5.3 4.5 8.7 13.7 7.7 10.0 5.6 5.3 3.7 6.6 0.0 4.0 4.5 5.5 7.3 0.0 4.5 5.3 15.9 15.1 5.5 2.4 5.2 5.2 3.8 1.7 3.6 9.3 22.1 2.9 5.8 8.9 4.5 22.8 0.0 6.1 8.8 25.4 4.3 8.0 5.0 7.3 7.4 MERTK "c-Eyk, mer, RP38, Tyro12" ENSG00000153208 "MER proto-oncogene, tyrosine kinase" Q12866 2 111898479-112029561 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease mutation, Proto-oncogene, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Ito cells: 36.8;Kupffer cells: 92.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "intermediate monocyte: 10.3;non-classical monocyte: 6.4" "Lineage enriched" "Detected in single" 48 "monocytes: 10.3" "Cell line enhanced" "Detected in many" "CACO-2: 21.3;Hep G2: 22.1;HUVEC TERT2: 22.0;RT4: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036196, HPA075622" Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol" NA NA 29000000 "Plasma membrane" "Endoplasmic reticulum, Midbody, Cytosol" "HPA036196: AB_10670676, HPA075622: AB_2686759" "unprognostic (2.17e-2)" "unprognostic (8.10e-2)" "unprognostic (4.85e-2)" "unprognostic (2.68e-1)" "unprognostic (2.44e-1)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "prognostic favorable (4.74e-4)" "unprognostic (6.84e-2)" "unprognostic (1.25e-1)" "unprognostic (6.22e-2)" "unprognostic (3.72e-1)" "prognostic favorable (4.43e-5)" "unprognostic (5.13e-2)" "unprognostic (2.11e-1)" "unprognostic (5.86e-2)" "unprognostic (2.05e-2)" 20.1 55.1 13.1 12.5 17.8 1.9 31.8 6.2 13.8 10.8 13.8 6.8 27.7 11.5 11.3 25.4 8.4 12.8 11.7 7.1 16.5 6.3 14.2 18.9 12.7 30.3 8.1 10.1 12.9 9.0 23.9 14.3 18.4 18.6 14.1 7.9 20.4 6.8 24.9 6.4 6.4 12.8 13.6 12.2 38.4 12.3 17.3 9.8 1.7 9.9 2.0 8.4 14.1 26.6 0.0 0.2 0.1 10.3 0.0 0.0 0.3 0.5 0.9 4.4 10.0 0.2 0.1 7.1 0.0 0.1 0.5 1.0 21.3 1.3 0.1 4.7 0.0 4.6 0.1 5.8 0.0 0.8 0.8 3.1 3.8 0.0 22.1 0.1 0.1 0.9 0.2 0.0 5.1 0.3 2.3 22.0 0.8 1.2 2.0 1.7 1.0 0.0 5.0 2.7 0.6 3.4 1.4 1.2 1.7 11.2 13.1 0.1 4.2 0.1 0.3 1.7 1.6 0.0 0.2 3.3 0.6 2.0 0.0 0.0 1.7 2.5 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 6.4 0.1 0.0 0.3 13.1 17.8 6.2 13.8 16.5 6.3 8.1 10.1 18.6 9.8 3.0 20.1 0.8 2.9 1.4 0.6 2.1 5.1 1.4 11.4 0.0 2.0 2.6 1.7 0.8 1.6 7.1 1.6 0.0 0.8 1.0 4.1 2.0 0.0 8.9 23.6 0.0 0.0 36.8 92.6 1.5 4.6 11.0 0.0 0.0 2.3 8.6 1.7 1.9 6.3 1.9 9.2 6.5 11.3 0.5 1.5 1.1 15.8 0.8 1.8 1.4 NAT10 "FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43" ENSG00000135372 "N-acetyltransferase 10" Q9H0A0 11 34105602-34147670 "Plasma proteins, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035546, HPA057576, HPA071628" Approved Enhanced Nucleoli,Midbody Yes No Nucleoli Midbody "CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426" "unprognostic (3.04e-1)" "unprognostic (9.24e-2)" "unprognostic (2.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (1.07e-4)" "prognostic unfavorable (9.61e-8)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.12e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.83e-5)" "unprognostic (1.24e-1)" "unprognostic (7.18e-2)" "unprognostic (9.55e-2)" "unprognostic (8.69e-2)" 18.5 22.8 20.5 21.9 27.5 23.6 20.8 21.9 29.9 18.1 17.6 24.3 16.4 13.7 30.6 19.8 25.2 21.7 14.7 16.4 17.2 18.6 15.9 21.8 15.1 28.7 16.9 19.8 26.4 24.9 31.5 23.1 20.1 23.4 19.5 21.7 23.0 22.5 17.8 23.4 31.0 16.6 21.5 15.1 23.6 18.0 30.9 16.9 31.2 18.3 19.4 35.3 17.8 19.7 10.4 12.8 2.2 11.1 11.8 13.7 6.9 12.4 17.6 9.4 20.0 11.4 10.1 10.9 12.4 9.1 15.8 12.6 19.7 7.2 40.0 9.2 10.4 13.6 18.9 35.4 18.9 20.2 11.1 22.7 18.1 14.4 18.4 10.3 45.3 13.2 10.3 13.0 10.3 29.0 7.4 12.0 19.3 39.5 14.0 13.1 23.6 36.9 20.6 13.5 21.6 21.2 27.8 31.9 16.7 9.1 21.8 14.0 10.6 16.7 17.7 7.4 9.5 17.7 12.5 9.6 14.1 11.2 20.6 22.9 15.3 18.3 38.1 14.2 18.8 13.9 0.5 6.6 2.2 10.3 11.1 13.7 10.4 11.1 11.7 12.8 9.6 11.5 11.2 0.8 11.8 9.7 9.7 9.6 6.9 20.5 27.5 21.9 29.9 17.2 18.6 16.9 19.8 23.4 16.9 6.0 16.5 12.0 9.6 10.9 11.2 9.8 10.2 14.7 22.7 14.0 11.8 15.4 5.0 6.8 3.8 7.8 3.5 23.3 8.3 9.9 7.4 6.4 4.7 7.2 10.5 11.1 6.9 6.7 4.0 2.1 8.6 6.0 1.7 11.8 8.5 7.7 6.9 2.9 12.4 5.0 10.1 12.9 8.1 17.9 25.4 12.0 12.0 10.2 12.4 6.3 NEFL "CMT1F, CMT2E, NF68, NFL, PPP1R110" ENSG00000277586 "Neurofilament light" P07196 8 24950955-24957110 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.1" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 32.2;Distal tubular cells: 87.9;Horizontal cells: 28.6;Intestinal endocrine cells: 32.1;Muller glia cells: 29.9;Rod photoreceptor cells: 73.4" "Cancer enhanced" "Detected in many" "renal cancer: 24.0" "Cell type enriched" "Detected in some" 5 "memory CD4 T-cell: 13.7" "Lineage enriched" "Detected in single" 138 "T-cells: 13.7" "Group enriched" "Detected in some" 5 "HEK 293: 114.9;PC-3: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014850, HPA015021" Enhanced Supported Approved "Nucleoplasm,Intermediate filaments,Midbody" NA NA "Nucleoplasm, Intermediate filaments" Midbody "HPA014850: AB_1854397, HPA015021: AB_2669135" "unprognostic (7.63e-2)" "unprognostic (1.36e-2)" "unprognostic (9.53e-2)" "unprognostic (6.81e-2)" "unprognostic (2.82e-2)" "unprognostic (6.69e-2)" "unprognostic (3.69e-2)" "unprognostic (3.78e-3)" "unprognostic (3.06e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (4.91e-4)" "unprognostic (5.76e-3)" "unprognostic (7.88e-2)" "unprognostic (3.97e-3)" "unprognostic (3.17e-3)" 0.7 12.0 10.3 1.4 20.1 0.6 0.6 2.3 92.1 1.8 1.8 3.0 0.0 1.0 0.7 0.8 3.8 0.7 0.6 0.6 14.1 3.5 0.6 0.6 0.7 0.0 23.8 0.7 0.7 0.6 0.0 0.6 95.1 1.6 1.5 5.0 0.6 9.5 0.6 0.7 1.7 1.2 18.0 0.7 1.1 1.6 2.1 0.0 1.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 13.7 2.1 0.0 0.1 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.1 0.0 0.0 114.9 0.0 0.0 0.0 5.1 0.0 0.1 1.9 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.9 0.0 30.8 0.0 0.0 0.0 7.1 1.0 6.4 6.5 2.6 0.0 0.4 0.5 0.0 0.0 0.0 0.6 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.7 1.5 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 32.2 0.4 0.0 0.0 0.0 0.0 7.9 0.0 87.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 8.9 0.0 73.4 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 NEXMIF "KIAA2022, KIDLIA, MRX98, XPN" ENSG00000050030 "Neurite extension and migration factor" Q5QGS0 X 74732856-74925485 "Disease related genes, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.2;parathyroid gland: 9.0" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 2.2;Ciliated cells: 5.3;Club cells: 4.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HAP1: 6.7;Karpas-707: 10.8;SiHa: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000407 Uncertain Supported "Nucleoplasm,Midbody,Mitotic spindle,Cytosol" Yes NA Nucleoplasm "Midbody, Mitotic spindle, Cytosol" "HPA000407: AB_2665984" "unprognostic (1.04e-3)" "unprognostic (6.07e-5)" "unprognostic (1.81e-2)" "unprognostic (2.07e-5)" "unprognostic (2.15e-1)" "unprognostic (2.18e-2)" "unprognostic (3.37e-1)" "unprognostic (1.74e-3)" "unprognostic (3.71e-1)" "unprognostic (1.79e-2)" "unprognostic (1.64e-3)" "unprognostic (8.25e-2)" "unprognostic (7.58e-3)" "unprognostic (1.37e-2)" "unprognostic (3.80e-2)" "unprognostic (2.79e-4)" "unprognostic (6.94e-4)" 0.6 3.0 5.4 0.7 6.2 0.4 1.3 10.2 9.4 1.7 1.9 0.7 1.0 0.6 1.7 0.9 1.8 1.3 0.5 0.3 5.0 6.2 2.4 0.2 0.9 0.5 1.8 5.0 1.7 4.4 9.0 7.5 0.5 1.9 3.2 1.1 1.1 2.5 2.5 0.4 1.8 1.1 2.6 1.2 0.6 1.6 0.9 1.5 0.0 1.5 0.0 0.5 0.7 2.8 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 10.8 0.0 0.2 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 9.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.4 6.2 10.2 6.8 5.0 6.2 1.8 5.0 1.9 1.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB1 PCDH-GAMMA-B1 ENSG00000254221 "Protocadherin gamma subfamily B, 1" Q9Y5G3 5 141350102-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 32.2;pituitary gland: 13.7" "Group enriched" "Detected in some" 17 "Early spermatids: 5.4;Late spermatids: 5.9;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 14.7;ASC TERT1: 7.7;hTERT-RPE1: 8.0;T-47d: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA076182" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody" Yes No "Vesicles, Plasma membrane" "Nucleoplasm, Focal adhesion sites, Midbody" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: AB_2686783" "unprognostic (1.53e-2)" "unprognostic (1.94e-3)" "unprognostic (3.21e-1)" "unprognostic (4.38e-3)" "unprognostic (2.98e-1)" "unprognostic (8.36e-3)" "unprognostic (2.37e-1)" "unprognostic (9.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.78e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-2)" "unprognostic (1.93e-1)" "unprognostic (7.63e-3)" 2.3 2.7 8.2 1.4 7.5 1.0 2.1 4.3 32.2 2.5 1.4 9.4 0.1 1.2 3.7 2.0 1.7 1.9 2.1 2.2 7.6 5.7 2.1 1.3 2.4 1.2 5.5 5.0 4.1 2.8 1.4 13.7 1.6 7.0 2.5 1.4 2.6 1.7 3.1 1.1 1.4 1.3 3.0 6.9 1.4 1.2 1.5 5.6 0.0 2.5 0.0 1.2 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 2.0 1.8 0.0 14.7 7.7 0.1 1.4 3.6 0.5 0.8 0.2 0.5 0.5 4.7 0.5 3.5 0.6 0.4 0.2 0.5 0.0 0.9 0.0 0.2 1.3 0.2 0.0 0.1 1.2 0.0 0.0 0.0 8.0 0.1 0.0 0.2 0.2 3.3 1.8 0.4 0.3 0.2 0.0 0.0 0.0 2.7 0.1 0.0 0.0 1.1 0.8 0.0 0.9 0.1 1.5 9.6 0.0 1.1 0.2 1.6 1.2 0.0 0.0 2.6 0.3 2.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 7.5 4.3 9.6 7.6 5.7 5.5 5.0 7.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 PIK3CB PIK3C1 ENSG00000051382 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta" P42338 3 138652699-138834938 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Autophagy, Cell adhesion, Endocytosis" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 42.0;HMC-1: 66.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031938, HPA042288, HPA064207" Approved Supported Nucleoplasm,Nucleoli,Vesicles,Midbody Yes No Nucleoplasm "Nucleoli, Vesicles, Midbody" "CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212" "unprognostic (4.89e-2)" "unprognostic (1.42e-2)" "unprognostic (5.97e-2)" "unprognostic (7.85e-2)" "unprognostic (4.89e-2)" "unprognostic (6.01e-2)" "prognostic unfavorable (6.42e-4)" "unprognostic (3.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.99e-5)" "unprognostic (2.15e-1)" "unprognostic (6.18e-3)" "unprognostic (9.33e-2)" "unprognostic (7.82e-2)" "unprognostic (2.79e-1)" "unprognostic (4.59e-2)" 12.5 9.9 10.6 9.7 20.6 17.4 11.5 29.9 25.0 12.4 14.6 11.9 11.7 13.7 9.6 6.9 15.2 10.9 8.7 12.7 12.2 14.2 22.6 9.3 9.5 9.1 11.9 15.2 8.8 20.3 20.2 10.9 18.1 24.1 13.4 15.7 12.2 14.9 15.9 33.4 19.6 16.4 8.3 12.5 9.9 11.0 6.4 10.7 14.4 37.4 7.1 11.9 13.4 11.0 4.6 9.1 11.3 7.8 1.3 6.5 2.6 23.0 10.0 4.3 3.6 3.9 5.3 29.3 5.4 5.2 5.5 5.9 10.7 8.8 9.3 14.8 5.3 10.6 9.9 5.6 8.6 9.9 11.8 6.3 42.0 6.8 6.4 4.0 10.2 66.6 4.5 6.6 3.8 7.8 9.8 8.3 4.5 16.0 6.9 6.9 10.6 5.9 7.2 6.2 17.0 9.4 4.3 4.5 6.6 8.5 12.8 3.7 2.7 15.0 6.5 19.3 13.2 16.3 24.4 8.7 3.5 4.5 7.7 7.6 11.7 7.6 8.5 8.6 9.9 4.9 7.0 7.8 11.3 4.0 4.5 2.7 4.6 5.2 3.0 9.1 4.1 6.5 4.4 10.0 1.3 4.3 1.4 2.2 2.6 10.6 20.6 29.9 25.0 12.2 14.2 11.9 15.2 24.1 10.7 8.9 14.7 4.7 12.9 16.9 15.4 30.2 12.7 14.7 21.6 17.4 23.6 29.1 5.0 9.4 0.9 8.5 21.3 0.0 16.5 46.3 6.5 23.0 13.9 15.8 13.4 20.6 15.6 11.6 28.8 1.1 3.4 19.7 6.8 14.4 14.9 8.2 15.2 21.8 6.3 18.9 17.9 6.5 6.1 10.7 14.9 20.5 40.0 6.1 12.7 15.3 PRC1 ASE1 ENSG00000198901 "Protein regulator of cytokinesis 1" O43663 15 90966038-90995629 "Predicted intracellular proteins" "Cell cycle, Cell division" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.3;lymphoid tissue: 44.5;testis: 44.3" "Group enriched" "Detected in many" 4 "Erythroid cells: 70.0;Extravillous trophoblasts: 59.0;Spermatocytes: 129.3;Spermatogonia: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basophil: 18.9;T-reg: 5.8" "Group enriched" "Detected in many" 6 "granulocytes: 18.9;T-cells: 5.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA034521, HPA048816" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody" Yes Yes "Plasma membrane, Microtubules, Cytokinetic bridge, Midbody" Nucleoplasm "HPA034521: AB_10670169, HPA048816: " "unprognostic (1.14e-1)" "unprognostic (3.98e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-3)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.24e-3)" "unprognostic (3.86e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (2.76e-5)" "unprognostic (2.49e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.79e-1)" "unprognostic (7.90e-2)" "unprognostic (3.92e-2)" 3.2 2.8 3.5 13.0 3.8 43.3 3.6 12.5 5.8 3.4 9.3 1.6 0.2 6.1 3.5 4.7 15.0 2.6 2.8 3.5 5.1 4.9 2.3 1.9 5.8 9.2 3.4 4.7 3.6 3.8 1.6 1.5 10.4 5.2 2.4 9.9 2.7 3.9 1.0 2.5 9.9 6.6 5.4 3.5 5.8 5.0 44.3 0.8 44.5 1.8 15.3 16.5 3.5 4.9 0.9 2.0 18.9 0.4 2.0 5.8 0.7 32.9 40.2 33.7 22.8 3.5 6.0 18.1 47.4 28.0 52.5 40.3 26.8 32.1 12.5 18.9 30.2 32.5 44.9 38.3 20.3 49.8 23.2 42.5 26.0 52.6 24.6 0.9 12.8 22.5 1.5 2.6 29.8 30.6 11.7 29.4 20.3 21.6 26.9 48.8 28.6 13.1 19.5 13.2 43.1 17.3 13.8 42.0 16.8 23.4 25.0 30.7 24.3 45.1 25.1 16.3 24.3 30.1 25.3 17.6 34.7 30.7 28.6 68.2 8.7 23.1 15.5 15.2 31.8 53.0 18.9 0.4 2.0 0.5 0.0 0.3 0.9 1.0 1.0 1.8 0.4 0.9 0.4 0.2 2.0 0.2 2.0 5.8 0.7 3.5 3.8 12.5 5.8 5.1 4.9 3.4 4.7 5.2 0.8 0.0 1.9 12.3 5.2 14.7 6.8 2.4 0.0 4.0 10.3 3.5 0.0 9.5 0.0 2.9 17.7 3.2 2.0 70.0 2.5 59.0 7.4 5.1 9.2 1.6 17.6 3.2 5.2 9.8 8.6 12.3 3.4 7.0 3.3 9.0 4.5 4.5 1.7 2.6 1.8 0.0 3.5 6.5 10.3 129.3 60.0 12.4 12.2 6.9 7.4 5.4 PRR16 DSC54 ENSG00000184838 "Proline rich 16" Q569H4 5 120464278-120687332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 13.7;Early spermatids: 13.9;Fibroblasts: 10.5;Horizontal cells: 14.3;Smooth muscle cells: 8.3" "Cancer enriched" "Detected in many" 5 "prostate cancer: 13.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 24.5;BJ hTERT+: 25.5;fHDF/TERT166: 30.7;HSkMC: 19.7;hTERT-RPE1: 32.1;LHCN-M2: 29.7;U-138 MG: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049254 Approved Approved Nucleoplasm,Midbody,Cytosol Yes No Nucleoplasm "Midbody, Cytosol" "HPA049254: AB_2680693" "unprognostic (1.71e-1)" "unprognostic (3.87e-2)" "unprognostic (3.45e-1)" "unprognostic (1.20e-1)" "unprognostic (6.61e-2)" "unprognostic (7.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.42e-2)" "unprognostic (8.33e-2)" "unprognostic (4.40e-2)" "unprognostic (2.76e-2)" "unprognostic (2.06e-1)" "unprognostic (2.54e-8)" "unprognostic (3.05e-2)" "unprognostic (9.13e-2)" "unprognostic (2.65e-1)" "unprognostic (2.38e-3)" 11.6 4.4 4.7 7.0 4.9 0.9 11.3 21.1 7.6 20.3 5.2 2.2 1.8 2.9 15.7 4.6 4.1 5.8 8.2 16.9 4.7 3.8 3.6 1.5 10.0 3.1 2.3 4.9 6.9 2.4 1.8 2.5 12.8 9.6 10.9 6.7 1.4 3.2 3.9 30.4 4.4 4.9 11.6 3.0 4.3 4.3 3.2 1.6 0.0 4.9 14.2 1.8 8.7 23.2 0.5 1.4 0.7 3.2 0.2 0.2 1.0 1.0 0.0 2.5 0.0 7.0 24.5 0.0 11.1 25.5 15.9 12.2 0.0 0.0 0.0 0.0 30.7 2.8 0.0 2.4 0.2 16.8 0.0 0.6 0.0 0.3 0.0 6.7 0.0 0.0 19.7 2.7 4.7 15.0 32.1 0.5 0.0 0.0 0.0 29.7 0.0 0.0 0.0 0.2 0.0 0.4 0.0 1.9 0.0 1.3 0.0 0.0 4.9 0.0 0.0 0.3 2.0 0.0 0.0 0.1 36.7 4.2 1.1 5.7 0.1 0.0 0.0 2.1 0.0 1.2 0.5 3.2 0.2 0.1 1.8 0.1 0.2 0.1 0.0 1.4 0.5 0.1 0.2 0.7 0.2 1.1 0.5 0.1 1.0 4.7 4.9 21.1 7.6 4.7 3.8 2.3 4.9 9.6 1.6 0.0 0.0 0.0 6.4 1.1 2.0 2.5 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.1 13.9 0.1 0.0 0.0 0.0 0.0 10.5 6.0 0.0 0.0 0.5 14.3 0.0 0.6 1.2 7.4 2.6 1.2 1.7 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.5 0.0 8.3 0.6 1.5 0.5 0.5 0.0 0.0 0.5 RCOR2 ENSG00000167771 "REST corepressor 2" Q8IZ40 11 63911221-63916844 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.6" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 18.1;NTERA-2: 23.4;SCLC-21H: 36.7;SH-SY5Y: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021638 Uncertain Approved Nucleoplasm,Vesicles,Midbody Yes NA Nucleoplasm "Vesicles, Midbody" "HPA021638: AB_10960885" "unprognostic (1.96e-2)" "unprognostic (1.15e-1)" "unprognostic (4.10e-2)" "unprognostic (1.98e-3)" "unprognostic (3.10e-2)" "unprognostic (5.86e-2)" "unprognostic (2.33e-4)" "unprognostic (8.64e-2)" "unprognostic (1.46e-1)" "unprognostic (4.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-3)" "unprognostic (2.62e-1)" "unprognostic (1.75e-1)" "unprognostic (3.51e-1)" "unprognostic (9.93e-2)" "unprognostic (6.06e-3)" 0.8 1.4 3.3 0.7 8.0 0.3 0.7 9.3 16.6 3.0 1.4 3.4 0.0 2.0 3.5 2.6 1.2 3.7 1.6 5.9 4.0 2.6 0.7 0.4 1.0 0.3 2.4 3.8 5.2 1.4 3.2 5.0 1.8 1.8 1.7 1.7 3.3 2.3 1.7 3.1 0.6 1.6 2.5 2.2 0.5 1.2 7.0 2.5 4.1 0.6 0.6 0.3 2.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 18.1 1.2 0.3 1.5 5.4 0.1 0.3 0.2 0.6 0.7 0.1 0.1 0.2 0.4 0.3 0.2 7.9 0.0 0.2 0.2 1.0 0.2 0.1 5.8 3.0 0.0 0.1 1.8 0.0 0.3 0.0 0.0 0.1 2.4 0.9 0.0 0.0 1.6 1.6 6.4 23.4 2.3 0.0 5.8 1.0 0.5 0.0 0.0 36.7 24.4 0.1 1.6 0.9 4.6 1.3 2.2 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 8.0 9.3 11.0 4.0 2.6 2.4 3.8 1.8 2.5 0.0 0.0 0.0 0.0 0.0 15.7 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.2 3.7 0.5 0.0 0.0 0.0 0.2 3.2 1.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.1 0.9 0.3 0.0 0.4 0.0 2.1 0.0 0.2 0.7 2.6 0.3 0.7 0.0 1.1 0.0 RTN4RL1 "DKFZp547J144, NgR3, NGRH2" ENSG00000185924 "Reticulon 4 receptor like 1" Q86UN2 17 1934677-2025345 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.3" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 17.9;Cone photoreceptor cells: 35.3;Horizontal cells: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.8;HaCaT: 10.8;hTCEpi: 10.3;T-47d: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044428 Uncertain Approved "Nucleoplasm,Plasma membrane,Actin filaments,Midbody" "Intracellular and membrane" NA NA "Actin filaments" "Nucleoplasm, Plasma membrane, Midbody" "HPA044428: AB_10963229" "unprognostic (5.23e-1)" "unprognostic (3.52e-2)" "unprognostic (2.06e-1)" "unprognostic (2.12e-1)" "unprognostic (2.93e-2)" "unprognostic (7.25e-2)" "unprognostic (2.61e-3)" "unprognostic (1.17e-1)" "unprognostic (8.97e-3)" "unprognostic (6.21e-2)" "unprognostic (2.55e-3)" "unprognostic (6.32e-3)" "prognostic unfavorable (7.69e-4)" "unprognostic (3.86e-2)" "unprognostic (1.05e-1)" "unprognostic (7.01e-2)" "unprognostic (3.15e-2)" 8.3 5.0 6.8 1.2 8.0 0.6 7.0 4.6 19.3 3.4 1.3 0.6 7.2 0.8 1.9 1.0 1.4 3.6 2.9 2.7 9.6 2.7 2.6 3.2 3.9 0.8 1.3 7.9 1.6 3.8 2.0 6.5 1.3 0.7 6.1 0.8 8.4 9.8 5.3 3.9 11.3 1.2 1.2 1.0 2.7 1.2 1.3 0.1 0.0 1.5 0.8 0.9 1.4 3.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.4 1.6 1.8 2.5 2.1 0.3 0.0 0.1 1.1 0.3 0.0 0.0 0.0 0.0 0.1 10.8 0.2 10.8 4.7 0.1 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 10.3 0.0 3.7 0.0 0.0 2.6 0.1 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.3 0.8 0.3 1.2 0.0 0.0 2.3 0.1 0.3 0.8 1.8 0.3 13.5 0.1 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 8.0 4.6 19.3 9.6 2.7 1.3 7.9 0.7 0.1 0.0 2.1 0.0 0.2 2.4 17.9 2.6 0.0 2.7 2.3 3.5 35.3 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 2.1 1.4 31.8 0.0 6.7 0.0 0.9 0.0 0.0 3.3 0.0 0.0 1.5 0.1 0.0 0.0 0.0 10.0 0.0 0.5 0.0 0.1 2.5 0.0 0.0 0.0 0.2 SAFB "HET, SAFB1" ENSG00000160633 "Scaffold attachment factor B" Q15424 19 5623035-5668478 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001969, HPA016832, HPA020076" Supported Enhanced Nucleoplasm,Midbody NA NA Nucleoplasm Midbody "CAB001969: , HPA016832: AB_1850622, HPA020076: AB_1850624" "unprognostic (2.41e-2)" "unprognostic (8.18e-3)" "unprognostic (6.66e-2)" "unprognostic (3.81e-3)" "unprognostic (6.50e-2)" "unprognostic (7.82e-2)" "unprognostic (1.62e-3)" "unprognostic (9.31e-2)" "unprognostic (5.76e-2)" "unprognostic (4.85e-2)" "prognostic favorable (9.75e-5)" "unprognostic (3.25e-2)" "unprognostic (3.53e-3)" "unprognostic (3.14e-2)" "unprognostic (2.67e-2)" "unprognostic (4.07e-1)" "prognostic favorable (1.70e-4)" 28.7 27.6 26.4 34.8 32.5 50.7 26.2 50.8 36.0 28.9 29.7 34.3 18.6 31.0 32.1 17.3 26.6 25.8 22.6 26.9 28.2 25.8 23.8 29.0 27.1 38.0 31.5 26.2 35.0 29.2 31.2 35.0 35.5 28.1 27.5 20.5 21.4 31.1 28.8 53.6 35.5 31.0 27.8 31.4 39.1 28.4 30.3 32.1 61.4 26.3 19.5 31.3 30.7 45.6 32.8 31.6 48.4 42.3 31.2 37.5 30.5 27.5 24.4 29.8 19.1 13.2 11.9 34.1 20.7 13.5 17.7 15.0 36.6 15.9 44.8 16.5 10.3 14.9 26.0 28.6 17.0 18.7 30.2 28.0 32.9 22.5 34.2 12.5 40.4 29.1 10.6 15.8 15.8 16.9 12.7 14.0 19.7 45.6 23.0 13.5 24.5 42.5 32.0 39.6 19.0 24.4 42.8 32.6 31.0 13.8 23.2 27.4 23.6 23.3 18.8 21.2 17.9 17.4 21.9 21.5 18.1 22.3 22.1 31.8 37.4 31.9 41.0 17.4 33.6 23.9 35.0 28.4 48.4 36.2 28.4 36.7 32.8 36.0 35.2 31.6 32.2 37.5 36.0 30.6 31.2 42.3 26.6 34.5 30.5 26.4 32.5 50.8 36.0 28.2 25.8 31.5 26.2 28.1 32.1 29.8 16.0 30.4 40.5 58.3 38.8 35.0 10.2 85.6 50.0 15.7 33.4 43.6 21.6 36.0 5.2 35.2 30.0 0.0 30.2 47.2 40.1 31.6 48.6 24.5 32.8 47.7 28.6 23.4 21.9 4.5 33.1 39.9 28.7 50.5 36.7 29.9 28.1 28.8 24.4 22.4 44.2 19.4 47.0 78.8 82.8 57.1 52.3 44.7 34.5 34.2 SEPT7 "CDC10, CDC3, SEPT7A" ENSG00000122545 "Septin 7" Q16181 7 35800932-35907105 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 1164.8;Sertoli cells: 802.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023309, HPA029524" Enhanced Enhanced "Nucleoli,Actin filaments,Midbody,Cytosol" Yes No 16000000 "Actin filaments" "Nucleoli, Midbody, Cytosol" "HPA023309: AB_10600093, HPA029524: AB_10601573" "unprognostic (7.91e-3)" "unprognostic (6.89e-3)" "unprognostic (9.49e-2)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (2.22e-2)" "prognostic unfavorable (2.37e-4)" "unprognostic (2.00e-2)" "unprognostic (4.43e-2)" "unprognostic (7.13e-2)" "unprognostic (3.56e-2)" "unprognostic (7.66e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (2.86e-2)" "unprognostic (1.74e-1)" "unprognostic (1.71e-1)" "unprognostic (2.43e-3)" 35.5 28.5 89.0 26.8 77.8 31.9 29.5 41.9 81.5 35.1 28.7 54.3 11.5 15.7 37.8 36.2 31.7 25.4 34.2 47.5 86.4 58.1 24.3 21.5 28.3 38.8 79.6 66.2 42.8 11.2 22.9 31.9 41.0 72.0 28.4 28.2 9.6 14.9 29.9 21.7 29.1 20.1 42.6 76.8 29.5 18.1 19.3 98.2 33.0 22.6 17.3 41.4 36.9 24.0 40.4 24.0 47.3 24.8 69.1 56.8 48.6 36.1 17.4 44.5 29.2 50.2 51.9 22.8 46.7 43.1 39.9 34.4 27.0 28.1 34.3 31.7 47.5 53.6 27.5 31.4 31.1 57.0 23.4 16.5 27.6 24.4 14.6 29.3 33.2 30.5 33.6 24.4 31.3 30.9 41.8 41.5 27.1 21.6 27.1 64.7 16.9 33.5 55.8 47.7 33.9 24.7 34.6 42.4 19.7 38.6 27.0 23.9 42.0 32.6 42.0 27.9 76.2 31.0 36.8 35.0 40.3 47.8 24.7 51.4 32.0 29.1 86.5 25.7 55.6 85.0 47.3 20.7 34.9 55.4 24.0 56.8 40.4 39.6 50.5 24.0 37.4 35.6 44.9 39.3 69.1 24.8 17.2 34.2 48.6 89.0 77.8 41.9 81.5 86.4 58.1 79.6 66.2 72.0 98.2 142.9 97.9 186.4 0.0 141.0 199.4 207.8 40.8 222.1 184.2 129.1 43.2 148.6 127.6 0.0 342.3 214.2 64.6 23.3 0.0 161.3 239.6 0.0 368.3 69.5 168.4 1164.8 58.6 187.2 128.6 256.8 324.7 171.1 178.8 0.0 61.0 328.2 0.0 106.6 426.0 108.1 113.7 802.0 509.2 101.6 233.2 140.9 103.9 294.1 77.5 0.0 SHCBP1 "FLJ22009, PAL" ENSG00000171241 "SHC binding and spindle associated 1" Q8NEM2 16 46580554-46621626 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.9;lymphoid tissue: 22.9;testis: 14.1" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 24.1;Spermatocytes: 27.0;Spermatogonia: 30.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA048876 Uncertain Approved "Nuclear bodies,Microtubules,Midbody,Mitotic spindle" Yes Yes "Nuclear bodies" "Microtubules, Midbody, Mitotic spindle" "HPA048876: AB_2680542" "unprognostic (2.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.98e-2)" "unprognostic (2.74e-1)" "unprognostic (2.54e-2)" "unprognostic (2.35e-2)" "unprognostic (2.96e-4)" "unprognostic (2.26e-3)" "unprognostic (5.35e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.47e-5)" "unprognostic (4.81e-2)" "unprognostic (2.22e-16)" "unprognostic (3.59e-2)" "unprognostic (3.86e-2)" "unprognostic (2.66e-1)" "unprognostic (2.66e-1)" 1.5 0.8 1.0 17.3 3.0 18.9 0.9 2.4 1.3 0.8 2.2 0.6 0.3 1.3 1.5 2.0 5.7 0.4 1.1 1.5 1.0 0.7 5.0 0.3 1.7 11.2 0.7 0.7 1.2 0.3 0.2 0.8 2.8 0.7 0.9 2.5 0.3 2.6 0.3 1.4 3.8 2.3 1.9 1.1 9.9 1.4 14.1 0.9 22.9 0.6 3.0 12.9 2.0 1.6 4.6 2.0 1.8 5.4 0.3 3.4 2.1 15.3 16.4 6.2 7.5 1.3 3.2 8.6 31.4 12.4 30.7 14.3 7.8 10.1 13.5 14.2 14.3 12.4 10.2 13.6 10.2 38.0 8.6 9.1 14.8 12.4 13.2 0.0 13.0 18.9 0.6 0.6 22.5 9.2 3.0 16.0 7.1 6.1 14.3 33.3 10.2 11.6 10.8 4.8 7.2 17.5 21.2 41.6 21.6 6.3 4.8 2.6 3.4 21.7 11.5 4.9 5.6 6.3 10.7 9.2 22.5 14.6 21.7 24.9 11.3 14.9 21.6 10.3 14.0 22.6 0.3 0.8 1.8 0.5 1.3 0.1 4.6 0.8 0.4 1.2 1.9 0.1 0.3 0.8 0.3 5.4 2.0 3.4 2.1 1.0 3.0 2.4 1.3 1.0 0.7 0.7 0.7 0.7 0.9 0.0 1.4 0.0 0.5 1.4 0.2 1.4 2.5 0.0 2.3 0.0 0.0 3.1 0.0 0.3 6.4 0.3 0.4 0.0 0.0 24.1 1.0 0.4 0.0 0.0 10.7 0.0 0.0 2.5 2.9 1.5 0.6 3.9 1.7 2.8 0.2 1.0 0.1 0.0 0.4 0.0 0.3 0.0 0.5 27.0 30.1 0.5 3.1 0.7 0.6 0.9 ST8SIA5 SIAT8E ENSG00000101638 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5" O15466 18 46667821-46759257 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 12.8;brain: 36.4" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 6.9;Collecting duct cells: 1.8;Early spermatids: 2.7;Late spermatids: 5.2" "Cancer enriched" "Detected in single" 8 "glioma: 2.6" "Region enhanced" "Detected in many" "cerebellum: 36.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "WM-115: 52.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043813, HPA046771" Approved Approved "Plasma membrane,Midbody" NA NA "Plasma membrane, Midbody" "HPA043813: AB_2678683, HPA046771: AB_2679798" "unprognostic (3.19e-2)" "unprognostic (1.16e-1)" "unprognostic (2.47e-2)" "unprognostic (1.33e-4)" "unprognostic (2.99e-2)" "unprognostic (4.83e-2)" "unprognostic (1.90e-2)" "unprognostic (1.39e-2)" "unprognostic (1.35e-1)" "unprognostic (1.36e-1)" "unprognostic (1.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.55e-2)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" 0.6 12.8 3.6 0.6 7.8 0.9 0.5 36.4 16.1 0.5 0.5 1.0 0.0 0.7 0.5 0.9 0.4 0.7 0.6 7.2 4.0 1.8 1.5 0.4 0.5 0.5 2.0 6.9 0.7 0.4 4.9 0.7 0.4 4.1 0.6 0.5 0.0 0.4 0.5 8.2 0.7 0.5 0.5 2.5 0.5 0.7 0.9 0.7 0.0 0.6 0.0 0.5 0.5 0.1 0.8 0.4 1.5 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.1 0.1 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 52.9 1.0 0.4 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.0 0.8 0.3 0.3 1.5 0.5 0.2 0.4 0.1 0.0 3.6 7.8 36.4 16.1 4.0 1.8 2.0 6.9 4.1 0.7 0.0 0.0 0.0 0.0 0.0 1.0 6.9 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.4 0.0 0.7 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 TMEM125 MGC17299 ENSG00000179178 "Transmembrane protein 125" Q96AQ2 1 43269994-43274002 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 73.6;salivary gland: 47.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 113.2;Alveolar cells type 2: 120.0;Enterocytes: 84.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 13.4;BEWO: 11.5;CACO-2: 10.5;CAPAN-2: 25.1;OE19: 16.0;SK-BR-3: 21.6;T-47d: 17.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015796 Approved Midbody,Cytosol NA NA "Midbody, Cytosol" "HPA015796: AB_1858081" "unprognostic (2.53e-3)" "unprognostic (8.70e-2)" "unprognostic (1.27e-1)" "unprognostic (1.52e-1)" "unprognostic (3.14e-2)" "unprognostic (8.50e-2)" "unprognostic (8.37e-3)" "prognostic favorable (5.11e-5)" "unprognostic (3.39e-1)" "unprognostic (1.11e-1)" "unprognostic (7.76e-2)" "unprognostic (1.26e-1)" "prognostic favorable (2.91e-9)" "unprognostic (1.86e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-1)" "unprognostic (5.16e-2)" 0.8 0.0 5.3 4.6 7.1 0.0 4.9 0.9 5.0 7.4 14.4 1.0 20.7 15.1 1.8 12.5 3.3 6.6 18.9 1.0 8.9 4.3 9.4 1.4 42.5 0.8 10.7 0.8 2.0 73.6 9.6 15.7 5.6 1.1 8.8 9.1 1.5 47.8 19.0 0.8 3.7 29.4 0.8 21.1 0.8 11.6 1.2 0.8 1.1 33.6 3.8 5.0 1.4 3.5 0.0 0.8 0.0 0.0 1.8 0.9 0.2 13.4 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 10.5 25.1 0.0 0.6 0.0 0.0 6.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.5 16.0 0.0 0.0 0.0 0.3 0.2 4.3 6.5 0.0 0.0 21.6 0.0 2.0 17.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.9 0.2 0.0 1.8 0.0 0.8 0.0 0.2 5.3 7.1 0.9 1.9 8.9 4.3 10.7 0.8 1.1 0.8 113.2 120.0 0.5 1.7 0.0 0.0 0.4 43.3 29.4 47.8 15.7 0.0 26.1 14.9 32.4 3.1 0.0 84.2 0.0 34.1 1.2 0.2 16.8 1.1 0.0 2.0 0.0 20.8 0.0 0.0 6.0 0.3 0.8 0.0 1.0 59.6 1.7 27.0 37.4 1.1 23.1 0.0 0.0 0.2 1.0 0.2 0.4 6.1 0.0 32.2 5.4 TMEM86B MGC30208 ENSG00000180089 "Transmembrane protein 86B" Q8N661 19 55226639-55229264 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 15.1" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 30.6;Hepatocytes: 28.9" "Cancer enriched" "Detected in all" 5 "liver cancer: 10.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA057689 Uncertain Uncertain Midbody,Centrosome Yes No Centrosome Midbody "HPA057689: AB_2683504" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.76e-5)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (6.55e-2)" "prognostic favorable (3.13e-4)" "unprognostic (1.10e-2)" "unprognostic (2.00e-1)" "unprognostic (2.10e-1)" "prognostic favorable (9.97e-6)" "unprognostic (1.96e-2)" "unprognostic (6.63e-8)" "unprognostic (2.28e-1)" "unprognostic (1.07e-1)" "unprognostic (3.70e-1)" "unprognostic (3.19e-3)" 2.5 2.4 2.8 3.1 4.0 7.8 1.4 4.7 4.2 1.4 7.5 1.4 1.4 5.6 1.5 1.4 1.4 1.8 7.7 2.9 2.2 1.6 2.0 15.1 2.7 5.2 1.4 1.4 1.4 1.4 1.7 2.8 5.2 1.7 1.5 0.4 1.4 1.4 1.4 2.2 3.0 7.7 1.4 1.4 4.3 3.6 2.8 1.4 1.4 2.3 1.4 3.0 1.4 1.4 0.7 1.0 0.6 0.7 0.0 1.6 0.4 4.1 3.9 2.4 3.9 0.4 0.6 3.6 1.5 0.7 1.3 1.8 6.3 2.2 4.8 1.2 1.1 1.3 1.7 0.9 1.0 0.6 0.9 11.2 8.8 2.5 5.9 1.2 4.0 3.7 0.8 1.7 2.1 1.3 1.8 0.5 9.2 6.0 3.5 0.8 2.4 6.4 10.0 0.9 1.9 2.4 6.0 2.8 12.6 1.1 5.1 2.1 3.9 1.8 0.8 4.9 1.3 2.2 8.4 2.8 5.7 3.2 2.5 3.8 2.9 3.4 10.2 4.7 11.1 2.1 0.0 0.7 0.6 1.6 0.1 0.6 0.0 0.5 0.1 0.1 0.7 0.6 1.4 0.1 0.0 0.1 1.0 0.0 0.4 2.8 4.0 4.7 4.2 2.2 1.6 1.4 1.4 1.7 1.4 6.0 2.4 0.8 0.4 3.0 7.6 0.5 30.6 0.0 1.2 0.0 2.0 0.4 0.0 0.9 2.0 1.7 5.2 0.0 0.2 0.3 1.1 1.1 0.0 28.9 0.9 9.5 10.3 0.0 6.2 3.6 0.9 1.7 3.3 1.8 1.9 1.1 0.8 0.0 0.4 0.8 3.6 0.0 0.5 1.6 1.1 1.9 0.2 4.6 1.9 1.7 UHMK1 "KIS, Kist" ENSG00000152332 "U2AF homology motif kinase 1" Q8TAS1 1 162497251-162529629 "Enzymes, Predicted intracellular proteins" "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071190 Approved "Nucleoplasm,Golgi apparatus,Midbody" Yes No "Nucleoplasm, Golgi apparatus" Midbody "HPA071190: AB_2686358" "unprognostic (6.69e-2)" "unprognostic (1.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-1)" "unprognostic (2.08e-2)" "unprognostic (8.16e-2)" "unprognostic (9.63e-2)" "unprognostic (1.82e-1)" "unprognostic (7.81e-3)" "unprognostic (9.10e-2)" "unprognostic (3.11e-1)" "unprognostic (3.44e-2)" "unprognostic (9.08e-2)" "unprognostic (8.77e-2)" "unprognostic (4.66e-2)" 21.6 22.0 23.5 18.9 26.2 30.1 23.5 10.8 30.5 14.3 16.3 17.2 30.8 16.3 11.5 12.9 16.0 12.9 12.1 11.4 27.0 31.8 27.9 32.4 16.9 24.3 30.6 20.3 12.1 11.8 25.0 12.5 16.5 33.4 14.7 17.4 14.1 15.9 22.9 30.6 11.5 21.8 9.6 20.5 21.3 16.8 10.4 14.1 23.0 17.1 11.7 24.1 16.1 12.8 5.7 4.3 4.5 9.2 5.9 8.5 4.0 21.1 9.9 5.2 12.7 14.9 11.8 11.7 28.0 15.3 23.0 16.6 6.4 13.3 17.3 24.5 20.9 11.2 12.3 9.9 15.5 37.1 23.7 7.2 17.1 12.3 5.8 11.5 24.9 20.0 12.1 16.4 22.6 21.7 16.1 13.2 12.0 14.9 24.1 39.4 8.9 13.2 6.6 6.9 15.9 13.4 8.5 23.3 14.4 15.3 21.9 9.5 8.8 24.7 23.0 18.0 7.5 19.9 28.0 20.5 26.3 14.9 18.1 39.0 25.0 34.7 20.5 21.9 12.2 23.8 4.5 3.3 3.7 8.2 8.6 8.5 5.4 6.2 6.8 3.6 5.7 6.3 7.1 2.0 5.9 9.2 4.3 4.9 4.0 23.5 26.2 10.8 30.5 27.0 31.8 30.6 20.3 33.4 14.1 17.9 32.1 50.1 25.7 26.2 21.7 29.4 56.0 41.5 50.0 50.6 11.8 22.6 48.0 23.2 35.7 30.8 40.7 0.0 20.2 32.6 19.3 44.8 45.0 71.0 27.6 22.3 32.1 35.0 64.6 34.6 19.8 51.7 27.0 44.1 35.0 13.6 28.8 34.8 18.4 49.4 21.6 0.0 27.3 23.4 22.0 21.5 18.8 52.2 31.1 52.1 VPS4A "FLJ22197, SKD1, SKD1A, SKD2, VPS4, VPS4-1" ENSG00000132612 "Vacuolar protein sorting 4 homolog A" Q9UN37 16 69311356-69326939 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB018751, CAB034411, HPA060092" Approved Supported Midbody NA NA Midbody "CAB018751: AB_2215497, CAB034411: AB_2304400, HPA060092: AB_2684203" "unprognostic (2.60e-2)" "unprognostic (2.32e-2)" "unprognostic (1.26e-1)" "unprognostic (9.26e-2)" "unprognostic (4.03e-1)" "unprognostic (1.20e-1)" "unprognostic (2.55e-2)" "unprognostic (2.70e-2)" "unprognostic (4.63e-2)" "unprognostic (8.61e-2)" "unprognostic (3.91e-3)" "unprognostic (2.19e-1)" "prognostic favorable (1.76e-4)" "unprognostic (5.44e-2)" "unprognostic (1.46e-1)" "unprognostic (2.61e-1)" "unprognostic (6.79e-2)" 20.2 19.6 24.8 14.4 26.5 13.0 24.2 28.7 35.6 12.9 17.8 19.3 14.5 22.0 16.6 14.5 26.3 16.0 16.1 34.3 24.4 22.8 23.2 13.7 15.8 17.5 25.4 29.3 21.0 31.4 29.7 9.6 16.6 33.6 17.5 13.2 15.6 30.4 15.5 81.6 24.3 20.5 18.4 34.3 15.0 18.9 15.5 17.4 8.9 27.5 21.1 13.0 15.6 21.2 11.1 11.6 15.7 13.1 9.3 18.1 14.4 11.0 19.0 13.2 17.3 11.9 10.6 11.5 15.1 13.7 20.1 13.5 17.9 10.5 18.8 15.1 15.0 9.9 16.7 13.0 15.2 12.2 7.8 16.9 11.8 11.4 14.4 18.5 14.7 11.0 12.2 20.0 17.4 15.9 12.3 14.9 15.2 19.5 5.7 14.8 24.8 19.0 11.1 14.9 11.2 13.4 25.7 10.6 22.0 10.1 9.1 22.0 14.0 32.3 10.1 11.5 9.2 17.6 11.1 17.7 18.6 11.7 16.9 11.7 20.5 16.2 34.1 17.1 10.0 20.4 10.0 11.6 15.7 14.6 10.2 13.3 11.1 12.3 18.1 11.6 10.1 14.3 13.0 9.5 9.3 13.1 6.8 13.8 14.4 24.8 26.5 28.7 35.6 24.4 22.8 25.4 29.3 33.6 17.4 23.8 21.3 28.2 30.2 27.2 53.3 26.2 20.4 5.3 11.4 22.7 21.6 49.8 63.0 45.4 7.2 30.7 47.9 0.0 71.8 54.7 29.7 38.7 28.8 20.2 39.8 69.9 30.1 27.0 23.4 7.7 27.3 27.5 42.2 45.9 31.5 52.2 53.2 38.7 28.7 46.3 36.1 51.8 37.6 27.3 33.4 27.4 58.6 36.7 35.7 36.3 WIZ ZNF803 ENSG00000011451 "Widely interspaced zinc finger motifs" O95785 19 15419980-15449951 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022923, HPA023774" Supported Enhanced Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA022923: AB_1858845, HPA023774: AB_2671308" "unprognostic (3.50e-2)" "unprognostic (3.91e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (5.12e-5)" "unprognostic (1.05e-1)" "unprognostic (4.96e-3)" "unprognostic (9.73e-3)" "unprognostic (3.00e-1)" "unprognostic (2.24e-2)" "unprognostic (4.69e-2)" "unprognostic (7.46e-2)" "unprognostic (5.47e-2)" "unprognostic (2.65e-1)" "unprognostic (4.27e-2)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (2.11e-1)" 28.0 17.5 27.6 18.3 21.6 13.6 20.9 15.8 24.4 17.5 17.3 12.8 18.0 18.2 25.2 12.0 16.3 16.3 15.3 17.3 23.0 11.4 13.8 18.4 13.5 17.5 14.1 19.0 21.6 26.9 14.3 10.9 13.7 13.7 17.4 7.7 12.4 21.9 23.1 24.4 21.5 16.8 16.5 11.9 18.0 15.6 40.9 15.8 18.6 13.3 14.6 12.1 19.3 21.4 2.0 1.5 0.7 3.6 2.5 1.2 0.5 13.5 9.3 13.4 17.0 19.3 7.9 10.9 14.2 7.0 11.9 8.2 8.2 25.5 11.3 23.5 12.9 7.2 11.6 7.3 10.0 2.9 8.8 12.5 8.2 7.2 6.4 12.3 9.4 12.3 14.0 13.2 8.6 9.4 7.4 10.7 8.9 12.8 9.7 8.0 27.6 17.1 8.7 18.1 13.3 22.2 16.0 6.1 11.4 7.7 10.6 18.3 23.3 12.5 11.4 9.2 4.8 12.5 8.9 17.2 27.3 10.8 21.4 18.1 14.4 8.6 12.2 11.4 11.4 18.4 0.0 1.4 0.0 1.2 1.2 1.0 0.5 0.8 1.2 1.0 2.0 1.0 1.0 0.7 2.5 3.6 1.5 0.8 0.5 27.6 21.6 15.8 24.4 23.0 11.4 14.1 19.0 13.7 15.8 11.9 5.8 8.5 5.5 14.1 8.8 9.1 12.7 0.0 3.4 12.2 0.0 6.1 3.3 12.3 6.3 13.5 5.0 0.0 17.1 8.3 9.9 8.6 1.1 13.2 6.7 6.4 6.4 13.5 10.2 6.4 14.7 7.1 6.8 5.4 9.5 7.1 16.5 0.0 18.0 4.7 7.5 12.9 10.8 27.2 26.0 17.8 6.2 4.4 10.5 11.8